FR2903008A1 - Cosmetic and/or dermatological aqueous/anhydrous composition useful e.g. as a skin care and make-up product, comprises UV radiation filtering system, containing an insoluble UV filter and a C-glycoside derivative - Google Patents

Abstract

Cosmetic and/or dermatological aqueous/anhydrous composition comprises a UV radiation filtering system, containing insoluble UV filter (II) and a C-glycoside derivative (I), in a support. An independent claim is included for a cosmetic and/or dermatological unit comprising a container comprising at least a compartment, the container being closed by a closing element and the cosmetic composition laid out inside the compartment.

Description

The invention relates to a cosmetic and / or dermatological composition

  comprising in a cosmetically acceptable support at least one UV radiation filtering system containing at least one insoluble UV filter and at least one C-glycoside derivative.

  It may especially be a composition of care and / or makeup. The invention also relates to the use of a C-glycoside derivative in a cosmetic and / or dermatological composition comprising at least one insoluble UV filter, for reducing bleaching and / or for improving the spreading and feel after application.

  It is well known that the luminous radiations of wavelengths between 280 nm and 400 nm allow the browning of the human epidermis and that the wavelength rays between 280 and 320 nm, known under the name of UV-B, cause erythema and skin burns that can affect the development of natural tanning; this UV-B radiation must therefore be filtered.

  It is also known that UV-A rays of wavelengths between 320 and 400 nm, which cause browning of the skin, are capable of inducing an alteration thereof, especially in the case of a skin sensitive or skin continuously exposed to solar radiation. UV-A rays cause in particular a loss of elasticity of the skin and the appearance of wrinkles leading to premature aging. They promote the triggering of the erythematous reaction or amplify this reaction in some subjects and may even be the cause of phototoxic or allergic photo reactions. It is therefore desirable to also filter the UV-A radiation. With regard to this filter requirement UV-A and UV-B, there are currently protective cosmetic compositions of the human epidermis containing UV-A and UV-B filters. In general, the cosmetic compositions intended for the photoprotection of the skin contain organic UV filters and filters of mineral origin which function according to their chemical nature and their physical properties, by absorption, reflection or diffusion of the UV radiation.

  Very often, these are combinations of fat-soluble and / or water-soluble organic filters associated with metal oxide pigments such as TiO 2 titanium dioxide or ZnO zinc oxide.  In order to achieve significant efficiency levels it is now common practice for those skilled in the art to introduce the photoprotective agents in a large quantity, all the more so since the required level of efficiency is high.  For this purpose, inorganic or organic insoluble filters are commonly used which have the advantage of combining the absorption and diffusion / reflection properties to increase the protection indices.  While the introduction of these inorganic filters effectively improves significantly the level of effectiveness of the products containing them, they also have an unfortunate tendency to increase the whitening appearance upon application of the composition, to cause Feelings of dryness and drying on the skin in case of a large and regular use of the products.  Also known in the prior art micronized insoluble organic UV filters of average particle size ranging from 10 nm to 2 m which have the advantage of being more effective than their soluble counterparts having the same chromophore group at an equivalent rate. .  This type of UV filters is in particular described in patent applications EP 746 305 and EP 893 119.  However, some solar formulations containing this type of filter tend to be difficult to spread and after application to make the skin rough and leave a residual white film.  The consumer is increasingly looking for effective products but also with great ease of application and comfort extended over time.  Thus, there is still a need to have compositions which provide good cosmetic performance with effectiveness, while having a cosmetic approval of use and of important application, especially in the case of products containing photoprotective agents such as organic insoluble filters. or minerals.  Sugar and sugar derivatives are products already used for various purposes for the formulation of cosmetic compositions intended both for the care of the skin and the care and / or washing of keratinous fibers.  In particular, certain C-glycoside derivatives are already known to exhibit interesting biological properties, in particular for combating aging of the epidermis and / or drying of the skin.  Such compounds are described in particular in WO 02/051828.  Unexpectedly, the inventors have discovered that the aforementioned drawbacks of the filtering compositions can be solved by using in these photoprotective compositions a C-glycoside derivative.  The photoprotective compositions thus obtained have good spreading, and after application a better feel, namely a non-glossy, non-sticky residual film, said residual film being of better quality, in particular not rough.  In addition, the phenomenon of parasitic bleaching conventionally observed with insoluble sunscreens is attenuated.  It is furthermore noted that the conventional antisolar compositions based on insoluble UV-screening agents, after application to the skin, lead to an uneven, inhomogeneous or even coarse distribution of the insoluble UV-filters on the skin, which can adversely affect the quality of the skin. overall protective effect sought.  This poor distribution that is found on the surface of the skin is often linked to the fact that there is, at the level of the emulsion, a substantial lack of homogeneity after application.  The inventors have also found, surprisingly, that the solar compositions containing at least one insoluble UV filter and at least one C-glycoside derivative make it possible to obtain a high protection factor, because of the better distribution of the filters on the skin.  These compositions also have good persistence to water, perspiration and washes and good persistence over time.  Thus, in accordance with one of the objects of the present invention, it is now proposed an aqueous cosmetic and / or dermatological composition comprising in a cosmetically acceptable support at least one UV radiation filtering system, characterized in that it contains (a) at least one insoluble UV filter, and (b) at least one C-glycoside derivative.  Within the meaning of the invention, the term "aqueous composition" is intended to denote any composition comprising at least 5% by weight of water and preferably from 5% to 99% by weight of water and even more preferably from 20% to 99% by weight. in weight of water, relative to the total weight of the composition.  Another object of the invention is a cosmetic and / or dermatological anhydrous composition comprising in a cosmetically acceptable support at least one UV radiation filtering system, characterized in that it contains: (a) at least one UV filter insoluble, and (b) at least one C-glycoside derivative.  For the purposes of the invention, the term "anhydrous composition" means any composition comprising less than 5% by weight of water and more preferably less than 1% by weight of water, relative to the total weight of the composition.  Another subject of the invention is the use of at least one C-glycoside derivative in a cosmetic and / or dermatological composition comprising, in a cosmetically acceptable support, at least one insoluble UV filter, in order to reduce the bleaching and / or improve spreading and touch after application.  In the remainder of the present description, the term "UV radiation filtering system" is understood to mean a UV radiation filtering agent consisting of either a single organic or mineral compound filtering the UV radiation or a mixture of several organic or inorganic compounds filtering the UV radiation. for example a mixture comprising a UV-A filter and a UV-B filter: In the remainder of the present description, the term "UV-insoluble" filter for the purposes of the present invention is understood to mean an organic or mineral compound that filters out UV radiation. having a solubility in water of less than 0.1% by weight and a solubility of less than 1% by weight in most organic solvents such as liquid paraffin, benzoates of fatty alcohols and triglycerides of fatty acids for example Miglyol 812 sold by the company DYNAMIT NOBEL.  This solubility, defined at 70 ° C. as the amount of product in solution in the equilibrium solvent with an excess of suspended solid, can easily be evaluated in the laboratory.  For the purposes of the present invention, the insoluble UV filter (s) are chosen from organic insoluble filters, inorganic insoluble filters and mixtures thereof.  Other features, aspects and advantages of the invention will appear on reading the detailed description which follows.  ORGANIC INSOLUBLE FILTERS The organic insoluble UV filter (s) comprising at least one UV-absorbing group may be chosen in particular from organic insoluble UV screening agents of the oxalanilide, triazine, benzotriazole or vinyl amide type. Cinnamide, benzazole, benzofuran, arylvinylidene ketone, acrylonitrile amide, acrylonitrile sulfonamide, acrylonitrile carbamate or phenylene-bis-benzoxazinone.  Among the oxalanilide-type organic insoluble UV-screening agents, mention may be made of those corresponding to the formula: (I) wherein Ti, TI ', T2 and T2' each independently represent a C1-C8 alkyl radical or an alkoxy radical in the form of C1-C8.  These compounds are described in the patent application WO 95/22959.  By way of examples, mention may be made of the commercial products TINUVIN 315 and TINUVIN 312 sold by the company CIBA-GEIGY corresponding respectively to the formulas: C2H5 OH NH, C ~ & J OC2HNFi II 'C' ~ NO II OC (CH3) The organic insoluble triazine type UV screening agents have the following general formula: ## STR3 ## wherein R 1, R 2 and R 3 are each independently unsubstituted phenyl, phenoxy or pyrrolo or each independently of one, two or three substituents selected from -OH, C1-C18 alkyl, C1-C18 alkoxy, carboxy (C1-C18 alkyl), C5-C8 cycloalkyl, methylbenzylidene-camphor, - (CH = CR ') - (CO) OR4 where R 'represents a hydrogen atom, a cyano group or a COOR4 group, with R4 = C1-C18 alkyl or cinnamyl, and n is 0 or 1.  These compounds are described in WO 97/03643, GB 2286774, EP 743309, WO 98/22447, GB 2319523 and EP-A-0 790 243.  The following compounds are more particularly mentioned: 2,4,6-tris (diethyl 4'-aminobenzalmalonate) -s-triazine, 2,4,6-tris (4'-amino benzalmalonate diisopropyl) - s-triazine, 2,4,6-tris (dimethyl 4'-aminobenzalmalonate) -s-triazine, ethyl 2,4,6-tris (4-cyano-4-aminocinnamate) - s-triazine.  Among the triazine-type organic insoluble UV filters which can be used for the present invention, there may also be mentioned the insoluble s-triazine derivatives bearing benzotriazole and / or benzothiazole groups such as those described in the application WO 98/25922.  Among these compounds, mention may be made more particularly of 2,4,6-tris [(3'-benzotriazol-2-yl-2'-hydroxy-5'-methyl) -phenylamino] -s-triazine and 2 4,6-tris [(3'-benzotriazol-2-yl-2'-hydroxy-5'-ter-octyl) -phenyl-amino] -s-triazine.  Among the triazine-type organic insoluble UV-screening agents which can be used for the present invention, mention may also be made of the insoluble derivatives of s-triazine, the symmetrical triazine filters described in US Pat. No. 6,225,467 and WO 2004/085412 (see compounds 6 and 9) or the document Symetical Triazine Derivatives IP. COM Journal, IP. COM INC WEST HENRIETTA, NY, US 25 (20 September 2004), especially 2,4,6-tris- (biphenyl) -1,3,5-triazines (especially 2,4,6-tris (biphenyl- 4-yl-1,3,5-triazine) and 2,4,6-tris (terpehnyl) -1,3,5-triazine which is incorporated in patent applications WO 06/035000, WO 06/034982, WO 06/034991, WO 06/035007, WO 2006/034992, WO 2006/034985).  Among the benzotriazole organic insoluble UV-screening agents, mention may be made of those of formula (III) below, described, for example, in the international application WO 95/22959: 2903008 7 R in which R5 denotes a hydrogen atom or a hydrogen atom. C1-C18 alkyl radical, R6 and R7, identical or different, each independently denote a C1-C18 alkyl radical optionally substituted with a phenyl group.  By way of examples of compounds of formula (III), mention may be made of the commercial products TINUVIN 328, 320, 234 and 350 of the company CIBA-GEIGY respectively corresponding to the following formulas: C (CH 3) 2 CH 2 CH 3 C (CH 3) 3 And the insoluble polytriazine type filters as mentioned in FR 2861075.  Among the benzotriazole-type organic insoluble UV filters, mention may also be made of the compounds described in patents US 5687521, US 5687521, US 5373037 and US 5362881, and among them in particular [2,4'-dihydroxy-3- (2H) benzotriazol-2-yl) -5 (1,1,3,3-tetramethylbutyl) -2'-n-octoxy-5'-benzoyl] -diphenylmethane of formula: 2903008 8 OH tertC8H17 Ni CH2 sold under the name MIXXIM PB30 by FAIRMOUNT CHEMICAL.  Other insoluble organic benzotriazole UV screening agents are methylene-bis (hydroxyphenylbenzotriazole) derivatives having the following structure: ## STR5 ## in which R 8 and R 9, which may be identical or different, each represent a C 1 -C 18 alkyl radical which may be substituted by one or more radicals selected from C 1 -C 4 alkyl, C 5 -C 12 cycloalkyl or aryl.  These compounds are known and are described in the applications US 5237071, US 5166355, GB-A-2 303549, DE 19726184 and EP-A-893119.  In the formula (IV) defined above, the C 1 -C 18 alkyl groups may be linear or branched and are, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, tert-butyl, and the like. octyl, n-amyl, n-hexyl, n-heptyl, n-octyl, isooctyl, n-nonyl, n-decyl, n-undecyl, n-dodecyl, tetradecyl, hexydecyl, or octadecyl; C 5 -C 12 cycloalkyl groups are, for example, cyclopentyl, cyclohexyl, cyclooctyl; aryl groups are for example phenyl, benzyl.  Among the compounds of formula (IV), those of the following structure are more particularly preferred: compound (a) compound (b) ## STR1 ## The compound (a) of nomenclature 2.2 Methylene bis [6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) phenol] is sold in solid form as MIXXIM BB / 100 by FAIRMOUNT. CHEMICAL and in micronized form under the name TINOSORB M by the company by CIBA SPECIALTY CHEMICALS.  Compound (c) 2,2'-methylene-bis- [6- (2H-benzotriazol-2-yl) -4- (methyl) phenol] is sold in solid form as MIXXIM BB / 200 by the company FAIRMOUNT CHEMICAL.  Among the organic insoluble vinyl amide type filters, there may be mentioned, for example, the compounds of formula (V) which are described in application WO 95/22959: T3- (Y) rC (= O) -C (T4 ) = C (Ts) -N (T6) (T7) (V) wherein T3 is a C1-C18 alkyl, preferably C1-C5 alkyl, or a phenyl group optionally substituted with one, two or three radicals selected from OH, C 1 -C 18 alkyl, C 1 -C 8 alkoxy or C (= O) -OT 8 wherein T 8 is C 1 -C 18 alkyl; T4, T5, T6 and T7 are each independently C1-C18 alkyl, preferably C1-C5, or hydrogen; Y is -NH- or oxygen and r is 0 or 1.  Among these compounds, there will be mentioned more particularly: 4-octylamino-3-penten-2-one; ethyl 3-octylamino-2-butenoate; 3-octylamino-1-phenyl-2-buten-1-one and 3-dodecylamino-1-phenyl-2-buten-1-one.  Among the cinnamid-type organic insoluble filters, mention may be made of compounds such as those described in patent application WO 95/22959 and having the following formula: ## STR1 ## in which Rlo represents a hydrogen atom or a C1-C4 alkyl group, preferably methyl or ethyl, - R11 represents a hydrogen atom or a C1-C4 alkyl group, preferably methyl or ethyl, R12 represents a group ù (CONH) s-phenyl where s is 0 or 1 and the phenyl group may be substituted with one, two or three groups selected from OH, C 1 -C 18 alkyl, C 1 -C 8 alkoxy or C (= O) -OR 13 where R 13 is C 1 alkyl -C 18, and more preferably R 12 is phenyl, 4-methoxyphenyl or phenylaminocarbonyl.  The bis-substituted dimers OQbis-cinnamides, described for example in US Pat. No. 5,888,481, of structure: (VII) in which Art and Ar2, which are identical or different, each represent a phenyl radical, may also be mentioned. , an aromatic heterocycle, a fused phenyl ring group or a fused aromatic heterocycle group, and may bear one or more substituents, identical or different, B and D, different from a hydrogen atom, each independently represent a radical organic, A and C each independently represent an organic radical, and - E represents a divalent organic radical, with the exception of the compounds for which Art and Ar2 both represent a phenyl group carrying a substituent OR where R represents a hydrogen atom hydrogen or an organic radical, A and C both represent a cyano group, B and D both represent a C 1 -C 35 alkyl or alkenyl group, and E represents a divalent organic radical, and in particular the structural compound: Among the insoluble organic benzazole type filters, there may be mentioned those corresponding to one of the following formulas: (VIII) (A) p 2903008 12 (R14) m (X) (R14) m wherein each of Y is independently oxygen or sulfur or NR15, each of Z is independently N or CH, each R14 independently represents an OH group, a halogen atom, a linear or branched C1-C8 alkyl group, optionally containing a silicon atom, or a linear or branched C1-C8 alkoxy group, each of the numbers m is independently 0, 1 or 2, n is an integer from 1 to 4 inclusive, p is 0 or 1, each of the numbers q is independently 0 or 1, each of R15 is independently hydrogen a benzyl group or al C1-C8 alkyl, linear or branched, optionally containing a silicon atom, A represents a radical of valence n chosen from those of formulas: 2903008 13 (b) (c) (d) (e) (f) (g) (h) (o) (i) (k) R17 (I) N (Rt6) e W (R16) wherein each of R16 is independently a halogen atom or a C1-4 alkyl or alkoxy group, linear or branched, or hydroxy, R17 represents a hydrogen atom or a C1-C4 alkyl group, linear or branched, c 5 = 0-4, d = 0-3, e = 0 or 1 andf = 0-2.  These compounds are described in particular in DE 676 103 and CH 350763, US Patent 5501850, US Patent 5961960, Patent Application EP 0 669 323, US Patent 5518713, US Patent 2463264, Article J.  Am.  Chem.  10 Soc. 79, 5706 - 5708, 1957, the article published in J.  Am.  Chem.  Soc. , 82, 609-611, 1960, the patent application EP 0 921 126 and the patent application EP 0712855.  As examples of preferred compounds of formula (VIII) of the 2-arylbenzazole family, mention may be made of 2-benzoxazol-2-yl-4-methylphenol, 2- (1H-benzimidazol-2-yl) - 4-methoxyphenol or 2-benzothiazol-2-ylphenol, these compounds can be prepared for example according to the methods described in patent CH 350 763.  As examples of preferred compounds of formula (VIII) of the family of benzimidazolylbenzazoles, mention will be made of 2,2'-bis-benzimidazole, 5,5 ', 6,6'-tetramethyl-2,2'-bis benzimidazole, 5,5'-dimethyl-2,2'-bis-benzimidazole, 6-methoxy-2,2'-bisbenzimidazole, 2- (1H-benzimidazol-2-yl) benzothiazole, 2- (1H-Benzimidazol-2-yl) -2-benzoxazole and N, N'-dimethyl-2,2'-bis-benzimidazole, these compounds being capable of being prepared according to the procedures described in US Pat. No. 5,796,960 and US Pat. No. 2,464,264.  Examples of preferred compounds of formula (VIII) of the phenylene benzazole family are 1,4-phenylenebis (2-benzoxazolyl), 1,4-phenylenebisb (2 benzimidazolyl), 1,3-phenylenebis (2-benzoxazolyl), 1,2-phenylenebis (2-benzoxazolyl), 1,2-phenylenebis (benzimidazolyl), 1, 4-phenylene-bis- (N-2-ethylhexyl-2-benzimidazolyl) and 1,4-phenylene-bis- (N-trimethylsilylmethyl-2-benzimidazolyl), these compounds can be prepared according to the procedures described in the patent US 2,463,264 and in the publications J.  Am. Chem.  Soc. , 82, 609 (1960) and J.  Am.  Chem.  Soc. 79, 5706-5708 (1957).  By way of examples of preferred compounds of formula (VIII) of the benzofuranyl-benzoxazole family, mention will be made of 2- (2-benzofuranyl) -benzoxazole, 2- (benzofuranyl) -5-methylbenzoxazole and 2- (3-benzofuranyl) benzoxazole. 2-methyl-2-benzofuranyl) -benzoxazole, these compounds may be prepared according to the procedures described in US Pat. No. 5,518,713.  Preferred compounds of formula (IX) include, for example, 2,6-diphenyl-1,7-dihydro-benzo [1,2-d; 4,5-d] -diimidazole corresponding to the formula: or 2,6-distyryl-1,7-dihydro-benzo [1,2-d; 4,5-d '] - diimidazole or else 2,6-di (p-tertbutylstyryl) -1,7-dihydrobenzo [1,2-d; 4,5-d '] - diimidazole, which can be prepared according to the processes described in application EP 0 669 323.  As preferred compound of formula (X), mention may be made of 5,5'-bis - [(phenyl-2) -25 benzimidazole] of formula: the preparation of which is described in J.  Chim.  Phys. , 64, 1602 (1967).  Of these organic insoluble compounds which filter UV radiation, 2- (1H-benzimidazol-2-yl) benzoxazole, 6-methoxy-2,2'-dichloro-2-benzimidazole, 2- (1H) are particularly preferred. benzimidazol-2-yl) -benzothiazole, 1,4-phenylene-bis- (2-benzoxazolyl), 1,4-phenylene-bis- (2-benzimidazolyl), 1,3-phenylene-bis- ( 2-benzoxazolyl), 1,2-phenylenebis (2-benzoxazolyl), 1,2-phenylenebis (2-benzimidazolyl) and 1,4-phenylenebis (N-trimethylsilylmethyl) -2- -benzimidazolyl).  Another family of insoluble filters is that of the arylvinylene ketones selected from those corresponding to one of the following formulas (XI) and (XII): embedded image in which: n = 1 or 2, 15 A, in the formula ( XI) when n = 1 or in the formula (XII), is an aryl radical chosen from the following formulas (a) to (d), or in the formula (XI) when n = 2, is a radical chosen from the formulas (e) to (h): A (o) (a) (b) (c) (d) (e) (f) (g) (h) wherein: each of R4 is independently an OH group , a halogen atom, a linear or branched C1-C6 alkyl group optionally containing a silicon atom, a C1-C6 alkoxy group, linear or branched and optionally containing a silicon atom, an alkoxycarbonyl group; C1-C5, linear or branched, or a C1-C6 alkylsulfonamide group, linear or branched and optionally containing a silicon atom or an amino acid function, 5 p represents an integer from 0 to 4 inclusive, q represents 0 or 1, R1 represents hydrogen or an OH group, R2 represents hydrogen, a linear or branched C1-C6 alkyl group and optionally containing an atom of silicon, a cyano group, a C1-C6 alkylsulfonyl group, a phenylsulfonyl group, R3 represents a linear or branched C1-C6 alkyl group and optionally containing a silicon atom or a phenyl group which can form a bicycle and optionally substituted by one or two radicals R4, or R2 and R3 together form a C2-C10 hydrocarbon residue which is monocyclic, bicyclic or tricylic, optionally interrupted by one or more nitrogen, sulfur and oxygen atoms and which may contain another carbonyl and optionally substituted by a linear or branched C1-C8 alkylsulfonamide group and optionally containing a silicon atom or an amino acid function; provided that when n = 1, R2 and R3 do not form a camphor ring.  By way of examples of compounds of formula (XI) in which n = 1, insoluble, filtering the UV radiation, there may be mentioned the following families: Styryl Ketone (Kao JP 04 134 042) such as 1- (3, 4-dimethoxy-phenyl) -4,4-dimethyl-pent-1-en-3-one: MeO OMe Benzylidene Cineole (E.  Mariani et al, 16th IFSCC Congress, New York (1990)) such as 1,3,3-trimethyl-5- (4-methoxy-benzylidene) -2-oxa-bicyclo [2. 2. 2] octan-6-one: OMe Benzylidene Chromanone (Kao JP 04 134 043) such as 3- (4-methoxy-benzylidene) -2,3,4a, 8a-tetrahydro-chromen-4-one: OO OMe 5 Benzylidene Thiochromanone (Kao JP 04 134 043) such as 3- (4-methoxy-benzylidene) -2,3,4a, 8a-tetrahydro-chromen-4-thione: OS OMe Benzylidene Quinuclidinone (Merck EP 0 576 974 ) such as 4-methoxybenzylidene-1-aza-bicyclo [2. 2. 2] Octan-3-one: Benzylidene Cycloalkanone (Henkel FR 2,395,023) such as 2- (4-methoxybenzylidene) -cyclopentanone and 2- (4-methoxy-benzylidene) -cyclohexanone: O MeO Benzylidene Hydantoin (Ajinomoto JP 01 158 090) such as 5- (3,4-dimethoxybenzylidene) imidazolidine-2,4-dione: OMe 10 MeO O MeO MeO O Benzylidene Indanone (Kao JP 04 134 043) such as 2- ( 4-methoxy-benzylidene) -indan-1-one: OMe Benzylidene tetralone (Kao JP 04 134 043) such as 2- (4-methoxy-benzylidene) -3,4-5 dihydro-2H-naphthalen-1-one Benzylidene Furanone (L'Oreal EP 0 390 683) such as 4- (4-methoxy-benzylidene) -2,2,5,5-tetramethyl-dihydro-furan-3-one: OMe Benzylidene Benzofuranone (Kao JP 04 134 041) such as 2-benzylidene-benzofuran-3-one: Benzylidene Indanedione such as 2- (3,5-di-tert-butyl-4-hydroxy-benzylidene) -indan-1,3-dione Benzylidene benzothiofuranone (Kao JP 04,134,043) such as 2-benzylidenebenzo [b] thiophen-3- Benzylidene barbiturate such as 5- (4-methoxy-benzylidene) -1,3-dimethyl-pyrimidine-2,4,6-trione: O-Benzylidene Pyrazolone such as 4- (4-methoxy-benzylidene) 5-methyl-2-phenyl-2,4-dihydro-pyrazol-3-one: imidazol-4-one: Benzylidene imidazolone such as 5- (4-methoxy-benzylidene) -2-phenyl- 3,5-dihydro-MeO Chalcone such as 1- (2-hydroxy-4-methoxy-phenyl) -3-phenyl-propenone: OH Benzylidene One (tautomeric filtering form of dibenzoylmethanes; L'Oréal FR 2,506,156) such as 3-hydroxy-1- (2-hydroxy-4-methoxy-phenyl) -3-phenylpropenone: Examples of compounds of formula (XI) in which n = 2, insoluble and filtering the UV radiation, there may be mentioned the following families: Phenylene bis methylidene-nor-camphor (Merck EP 0 693 471) such as 1,4-phenylene-bis- {3-methylidene bicyclo [2. 2. 1] heptan-2-one} Phenylenebis methylidene camphor (L'Oreal FR 2528420) such as 1,4-phenylenebis- {3-methylidene-1,7,7-trimethylbicyclo [2. 2. 1] heptan-2-one} or 1,3-phenylene-bis- {3-methylidene-1,7,7-trimethyl-bicyclo [2. 2. 1] heptan-2-one} Phenylenebis methylidene camphoresulfonamide (L'Oréal FR 2,529,887) such as 1,4-phenylene-bis-3,3'-methylidene camphor-10,10'-ethylsulfonamide or 2-ethylhexyl: Bp Phenylene bis methylidene cineole (E.  Mariani et al., 16th IFSCC Congress, New York (1990)) such as 1,4-phenylene-bis- {5-methylidene-3,3-dimethyl-2-oxa-bicyclo [2. 2. 2] octan-6-one}: O phenylene bis methylidene ketotricyclodecane (Merck EP 0 694 521) such as 1,4-phenylene-bis- (octahydro-4,7-methano-6-inden-5-one): or Phenylenebisalkylene ketone (Kao JP 04 134 041) such as 1,4-phenylene-bis- (4,4-dimethyl-pent-1-en-3-one): phenylene bis-methylidene furanone (L'Oreal) FR 2,638,354) such as 1,4-phenylenebis (4-methylidene-2,2,5,5-tetramethyl-dihydrofuran-3-one): OO phenylene bis methylidene quinuclidinone (Merck EP 0 714 880) such as 1,4-phenylene-bis- {2-methylidene-1 -aza-bicyclo [2. 2. 2] octan-3-one}: As compounds of formula (XII), there may be mentioned the following families: bis benzylidene cycloalkanone such as 2,5-dibenzylidene-cyclopentanone: gamma pyrone (Kao JP 04 290,882) such as 2,6-bis- (3,4-dimethoxy-phenyl) -pyran-4-one: OMe OMe Another family of insoluble filters for use in the present invention are amide, sulfonamide and carbamate derivatives. acrylonitrile corresponding to the following formula: wherein X 2 represents a divalent radical of formula - (C = O) - R '3 - (C = O) -, ù SO 2 - R "3-SO 2 - or - (C = O) -OR" 3-O- (C = O) -, Y represents a radical (C = O) -R 4 or -SO 2 R 5, R 2 represents a C 1 -C 4 alkyl group; 1-C8, linear or branched, n is 0, 1 or 2, R'3 represents a single bond or R "3 R" 3 represents a divalent radical C1-C30 alkylene or C3-C30 alkenylene, linear or branched which may carry one or more hydroxyl substituents and which may contain in the carbon chain, one or more heteroatoms chosen from oxygen, nitrogen and silicon atoms, R4 represents a radical -OR6 or -NHR6, R5 represents a linear or branched C1-C30 alkyl radical, or a phenyl ring which may be substituted with C 1 -C 4 alkyl or alkoxy radicals, R 6 represents a linear or branched C 1 -C 30 alkyl or C 3 -C 30 alkenyl radical which may carry one or more hydroxyl substituents and which may contain, in the carbon chain, one or more heteroatoms selected from oxygen, nitrogen and silicon.  Although in formula (XIII) above, only the isomers in which the cyano substituent is in the cis-position with respect to the para-amino-phenyl substituent are represented, this formula should be understood to include also the corresponding trans-isomers for each of the two double bonds and independently, the cyano and para-amino-phenyl substituents may be in the cis or trans configuration with respect to each other.  Another family of organic insoluble filters which can be used according to the present invention is formed by the phenylene-bis-benzoxazinone derivatives of the formula: R (XIV) OO in which R represents a divalent aromatic radical chosen from the formulas (e) to (h) ): (0) q (e) (f) (g) (h) wherein: each of R4 is independently an OH group, a halogen atom, a linear or branched C1-C6 alkyl group and optionally containing a silicon atom, a linear or branched C1-C6 alkoxy group optionally containing a silicon atom, a linear or branched C1-C6 alkoxycarbonyl group, or a linear C1-C6 alkylsulfonamide group; or branched and optionally containing a silicon atom or an amino acid function, p represents an integer between 0 and 4 inclusive, 2903008 q represents 0 or 1.  By way of examples of compounds of formula (XIV), which are insoluble and which filter UV radiation, the following derivatives may be mentioned: 2,2'-p-phenylene bis (3,1-benzoxazin-4-one), product CYASORB UV-3638 from CYTEC, 2,2 '- (4,4'-biphenylene) bis (3,1-benzoxazin-4-one), 2,2' - (2,6-naphthylene) bis ( 3,1-benzoxazin-4-one).  Another particular family of organic insoluble filters are polyvalent metal salts (eg Cal +, Zn 2+, Mg 2+, Bat +, A 13 + or Zr 4 +) of sulfonated or carboxylated organic filters such as polyvalent metal salts of sulfonated benzylidene camphor derivatives. such as those described in Application FR-A-2,639,347, the polyvalent metal salts of sulfonated benzimidazole derivatives such as those described in EP-A-893 119, and the polyvalent metal salts of acid derivatives. cinnamic such as those described in the application JP-87 166 517.  Mention may also be made of metal or ammonium or substituted ammonium complexes of organic UV-A and / or UV-B screening agents such as those described in patent applications WO 93/10753, WO 93/11095 and WO 95 / 05150.  The insoluble organic triazine or benzotriazole type screening agents may preferably be selected.  Among the triazine insoluble filters, it is more preferable to choose the symmetrical triazine filters described in US Pat. No. 6,225,467, the application WO 2004/085412 (see compounds 6 and 9) or the document Symetrical Triazine Derivatives IP. COM Journal, IP. COM INC WEST HENRIETTA, NY, US (20 September 2004) and in particular 2,4,6-tris (biphenyl-4-yl-1,3,5-triazine) and 2,4,6-tri ( terphenyl) - 1, 3, 5-triazine.  Among the insoluble benzotriazole filters, it is more preferable to choose the methylenebis (hydroxyphenylbenzotriazole) derivatives of the following structure: ## STR5 ## in which R 8 and R 9, which may be identical or different, each represent a C 1 -C 18 alkyl radical which may be be substituted with one or more radicals selected from C1-C4alkyl, C5-C12cycloalkyl or aryl and more particularly the compound (a) with 2,2'-methylene-bis- [6- (2H-benzotriazole) nomenclature; 2-yl) -4- (1,1,3,3-tetramethylbutyl) phenol] or Methylene bis-Benzotriazolyl tetramethylbutylphenol is sold in solid form the name MIXXIM BB / 100 by the company FAIRMOUNT CHEMICAL and in micronized form under the name TINOSORB M by the company by CIBA SPECIALTY CHEMICALS.  The organic insoluble filters according to the invention are generally in the form of particles of average size ranging from 10 nm to 5 m.  More preferably, their average size varies from 10 nm to 2 m, and in particular between 20 nm and 1.5 m, and more particularly between 30 nm and 1.0 m.  In general, the average particle size will be the average diameter of the number distribution.  The average size of the particles can be determined by any conventional method such as optical methods (quasi-elastic scattering or laser scattering), centrifugation methods or methods of microscopic visualization and image analysis.  The organic insoluble filters according to the invention can be brought into the desired particulate form by any suitable means such as in particular dry milling or in a solvent medium, sieving, atomization, micronisation, spraying.  The organic insoluble filters according to the invention in micronized form can in particular be obtained by a method of grinding an insoluble organic UV filter in the form of particles of coarse size in the presence of a suitable surfactant or an amphiphilic copolymer comprising at least one hydrophilic block and at least one hydrophobic block making it possible to improve the dispersion of the particles thus obtained in the cosmetic formulations.  An exemplary method for micronizing insoluble organic filters is described in GB-A-2,303,549 and EP-A-893,119 as an integral part of the specification.  The grinding apparatus used according to these documents may be a jet, ball, vibratory or hammer mill and preferably a high speed grinder or an impact mill and more particularly a rotary ball mill, a vibratory mill, tube mill or a rod mill.  According to this particular process, the alkylpolyglucosides of structure C 1, H 2n + (C 6 H 100 O) x H in which n is an integer of 8 to 16 and x is the average degree of deionization are used as surfactants for grinding said filters. polymerization of the unit (C6H1005) and varies from 1.4 to 1.6.  They can be chosen from C1-C12 esters of a compound of structure CnH2n + (C6H10O5) XH and more precisely an ester obtained by reaction of a C1-C12 carboxylic acid such as formic acid, acetic acid, propionic acid, butyric, sulphosuccinic, citric or tartaric with one or more free OH functions on the glucoside unit (C6H10O5).  Said surfactants are generally used at a concentration ranging from 1 to 50% by weight and more preferably from 5 to 40% by weight relative to the weight of organic insoluble filter in its micronized form.  It is also possible to improve the dispersibility of organic insoluble filters in the cosmetic support of amphiphilic copolymers comprising at least one hydrophilic block and at least one.  Hydrophobic sequence, such as those described in patent application EP 1 353 642.  MINERAL INSOLUBLE FILTERS Mineral insoluble UV filters are generally pigments which may be chosen from coated or uncoated metal oxides such as titanium dioxide (amorphous or crystallized in rutile and / or anatase form), iron oxides, zinc oxides, zirconium or cerium.  The pigments according to the invention preferably have an average particle size greater than 5 nm and less than 100 nm.  According to a particularly preferred embodiment of the invention, this size preferably varies from 10 nm to 50 nm.  According to one embodiment of the invention, the pigments may be nanopigments based on titanium oxide.  The pigments can be coated or uncoated.  The coated pigments are pigments which have undergone one or more surface treatments of a chemical, electronic, mechanochemical and / or mechanical nature with compounds as described for example in Cosmetics & Toiletries, February 1990, Vol.  105, p.  53-64, such as amino acids, beeswax, fatty acids, fatty alcohols, anionic surfactants, lecithins, sodium, potassium, zinc, iron or aluminum salts of fatty acids. metal alkoxides (of titanium or aluminum), polyethylene, silicones, proteins (collagen, elastin), alkanolamines, silicon oxides, metal oxides or sodium hexametaphosphate.  In a known manner, the silicones are organosilicon polymers or oligomers with a linear or cyclic, branched or crosslinked structure, of variable molecular weight, obtained by polymerization and / or polycondensation of suitably functionalized silanes, and essentially constituted by a repetition of main motifs in which the silicon atoms are connected to each other by oxygen atoms (siloxane bond), optionally substituted hydrocarbon radicals being directly bonded via a carbon atom to said silicon atoms.  The term silicones also includes the silanes necessary for their preparation, in particular alkyl silanes.  The silicones used for coating the pigments suitable for the present invention are preferably selected from the group containing alkyl silanes, polydialkylsiloxanes, and polyalkylhydrogensiloxanes.  Even more preferentially, the silicones are chosen from the group containing octyl trimethyl silane, polydimethylsiloxanes and polymethylhydro-genosiloxanes.  Of course, the metal oxide pigments before their treatment with silicones, may have been treated with other surfactants, in particular with cerium oxide, alumina, silica, aluminum, silicon compounds, or mixtures thereof.  The coated pigments are more particularly titanium oxides coated with silica, such as the product SUNVEIL from the company IKEDA, silica and iron oxide such as the product SUNVEIL F from the company IKEDA, 2903008 29-silica and alumina, such as the products MICROTITANIUM DIOXIDE MT 500 SA and MICROTITANIUM DIOXIDE MT 100 SA from the company TAYCA, TIOVEIL from the company TIOXIDE, alumina such as the products TIPAQUE TTO-55 (B) and TIPAQUE 5 TTO- 55 (A) from ISHIHARA, and UVT 14/4 from KEMIRA, - alumina and aluminum stearate such as MICROTITANIUM DIOXIDE MT 100 T, MT 100 TX, MT 100 Z, MT-01 from the company TAYCA, the products SOLAVEIL CT-10 W and SOLAVEIL CT 100 from the company UNIQEMA and the product EUSOLEX T-AVO from the company MERCK, 10-silica, alumina and alginic acid such as the product MT -100 AQ from the company TAYCA, - alumina and alumina laurate m such that the product MICROTITANIUM DIOXIDE MT 100 S from TAYCA, iron oxide and iron stearate such as the product MICROTITANIUM DIOXIDE MT 100 F from TAYCA, zinc oxide and stearate zinc such as the product BR351 from TAYCA, silica and alumina and treated with a silicone such as MICROTITANIUM DIOXIDE products MT 600 SAS, MICROTITANIUM DIOXIDE MT 20 500 SAS or MICROTITANIUM DIOXIDE MT 100 SAS from TAYCA of silica, alumina, aluminum stearate and treated with a silicone such as the product STT-30-DS from the company TITAN KOGYO, silica and treated with a silicone such as the product UV-TITAN X 195 of the company KEMIRA, 25-alumina and treated with a silicone such as TIPAQUE products TTO-55 (S) from the company ISHIHARA, or UV TITAN M 262 from the company KEMIRA, - triethanolamine such as the product STT -65-S from TITAN KOGYO, - stearic acid, such as the product TIPAQUE TTO-55 (C) from the company ISHIHARA, sodium hexametaphosphate such as the product MICROTITANIUM DIOXIDE MT 150 W from TAYCA.  Other pigments can be surface-treated with polyaspartic acid as described in WO 05/094156.  Other silicone-treated titanium oxide pigments are preferably octyl trimethyl silane-treated TiO 2 and the average particle size of which is between 25 and 40 nm, such as

  sold under the trade name T 805 by the company Degussa Silices, TiO 2 treated with a polydimethylsiloxane and whose average elementary particle size is 21 nm, such as that sold under the trade name 70250 CARDRE UF TiO2SI3 by CARDRE, TiO2 anatase / rutile treated with a polydimethylhydrogensiloxane and whose average elementary particle size is 25 nm, such as that sold under the trade name MICRO TITANIUM DIOXIDE USP GRADE HYDROPHOBIC by the company COLOR TECHNIQUES.  Uncoated titanium oxide pigments are for example sold by Tayca under the trade names MICROTITANIUM DIOXIDE MT 500 B or MICROTITANIUM DIOXIDE MT600 B, by DEGUSSA under the name P 25, by the company WACKHER under the name Transparent titanium oxide PW, by MIYOSHI KASEI under the name UFTR, by TOMEN under the name ITS and by TIOXIDE under the name TIOVEIL AQ.  The uncoated zinc oxide pigments are, for example: those marketed under the name Z-COTE by Sunsmart; those marketed under the name NANOX by the company ELEMENTIS; those marketed under the name NANOGARD WCD 2025 by the company NANOPHASE TECHNOLOGIES; The coated zinc oxide pigments are, for example: those sold under the name OXIDE ZINC CS-5 by the company Toshibi (ZnO coated with polymethylhydrogenosiloxane); those marketed under the name NANOGARD ZINC OXIDE FN by NANOPHASE TECHNOLOGIES (as a 40% dispersion in Finsolv TN, C12-C15 alcohol benzoate); those sold under the name DAITOPERSION ZN-30 and DAITOPERSION ZN-50 by the company Daito (dispersions in 2903008 cyclopolymethylsiloxane / polydimethylsiloxane oxyethylenated, containing 30% or 50% of zinc nano-oxides coated with silica and polymethylhydrogensiloxane); those marketed under the name NFD ULTRAFINE ZNO by the company Daikin (ZnO coated with perfluoroalkyl phosphate and a copolymer based on perfluoroalkylethyl dispersed in cyclopentasiloxane); those marketed under the name SPD-Z1 by Shin-Etsu (ZnO coated with silicone-grafted acrylic polymer, dispersed in cyclodimethylsiloxane); those marketed under the name Escalol Z100 by the company ISP (ZnO treated with alumina and dispersed in the ethylhexyl methoxycinnamate / PVP-hexadecene / methicone copolymer mixture); those marketed under the name FUJI ZNO-SMS-10 by Fuji Pigment (ZnO coated with silica and polymethylsilsesquioxane); those marketed under the name NANOX GEL TN by Elementis (ZnO dispersed at 55% in benzoate of C12-C15 alcohols with polycondensate of hydroxystearic acid).  The uncoated cerium oxide pigments are sold under the name COLLOIDAL CERIUM OXIDE by the company RHONE POULENC.  Uncoated iron oxide pigments are for example sold by ARNAUD under the names NANOGARD WCD 2002 (FE 45B).  , NANOGARD IRON FE 45 BL AQ, NANOGARD FE 45R AQ, NANOGARD WCD 2006 (FE 45R), or by the company MITSUBISHI under the name TY-220.  The coated iron oxide pigments are for example sold by ARNAUD under the names NANOGARD WCD 2008 (FE 45B FN), NANOGARD WCD 2009 (FE 45B 556), NANOGARD FE 45 BL 345, NANOGARD FE 45 25 BL, or by BASF under the name OXIDE DE FER TRANSPARENT.  The pigments can also be doped with metal ions such as iron, manganese and especially with manganese as in the Optisol range sold by Oxonica: Optisol ZM, Optisol TM.  Mention may also be made of mixtures of metal oxides, in particular of titanium dioxide and cerium dioxide, of which the titanium dioxide and cerium-coated cerium dioxide equivalent mixture, sold by the company IKEDA under the trademark SUNVEIL A as well as the mixture of titanium dioxide and zinc dioxide coated with alumina, silica and silicone, such as the product M 261 sold by the company Kemira or coated with alumina, silica and glycerin, such as the product M 211 sold by the company Kemira.  According to the invention, titanium oxide pigments, coated or uncoated, are particularly preferred.  The titanium oxide may be in rutile, anatase or amorphous form, but preferably in rutile and / or anatase form and / or in amorphous or substantially amorphous form.  The insoluble filter (s) may be present in the composition of the present invention at a content expressed as active ingredient of between 0.1 and 35% by weight, preferably between 0.5 and 25% by weight, relative to the total weight of the composition.  The insoluble filter may be a mixture of organic insoluble filters, a mixture of organic insoluble filters, a mixture of inorganic insoluble filters or mixtures of organic and inorganic filter (s).  When the composition comprises only one or more insoluble organic filter (s), the organic insoluble UV screening agent (s) of the invention are preferably present at a total concentration of active ingredient of between 0.1 and About 25% by weight, and preferably between about 0.2 and 20% by weight, based on the total weight of the composition.  When the composition comprises only one or more mineral insoluble filter (s), the mineral insoluble filters or pigments according to the invention generally represent from 0.1 to 40%, preferably from 0.15 to 30%, of the total weight of the composition.  When finally the composition comprises a mixture of organic insoluble filter (s) and insoluble mineral filter (s), the organic insoluble filter (s) are present at a concentration expressed as active ingredient of between 0.1 and 25% by weight relative to the total weight of the composition, while the insoluble mineral filter (s) are present at a concentration of concentration of between 0.1 and 15% by weight relative to the total weight of the composition, preferably according to this alternative, the organic insoluble filter (s) are present at a concentration of between 0, 5 and 20% by weight relative to the total weight of the composition, while the mineral insoluble filter (s) are present at a concentration of between 0.15 and 0.15. 10% by weight relative to the total weight of the composition.  C-GLYCOSIDE DERIVATIVES A C-glycoside derivative suitable for the invention may be a compound of the following general formula (I): in which - R represents.  a linear, saturated C1 to C20, in particular C1 to C10, or unsaturated C2 to C20, in particular C 2 to C 10, alkyl radical, or a C 3 to C 20 saturated or unsaturated branched or cyclic alkyl radical, in in particular at C3 to C10; a linear hydrofluoro- or perfluoroalkyl radical, linear saturated C1 to C20, in particular C1 to C10, or unsaturated C2 to C20, in particular C2 to C10, or branched or cyclic, saturated or unsaturated, C3 to C20 especially C3-C10; the hydrocarbon-based chain constituting said radicals may, if appropriate, be interrupted by 1, 2, 3 or more heteroatoms chosen from: - oxygen, - sulfur, nitrogen, and silicon, and which may be optionally substituted by at least one radical chosen from: -OR4, -SR4, -NR4R5, -COOR4, -CONHR4, -CN, a halogen atom, -a C1-C6 hydrofluoro- or perfluoroalkyl radical, and / or A C 3 -C 8 cycloalkyl radical, with R 4 and R 5 being independently of one another a hydrogen atom, or a saturated C 1 -C 30 alkyl, perfluoroalkyl or hydrofluoroalkyl radical, especially C1 to C12, or unsaturated C2 to C30, especially C2 to C12, or branched or cyclic, saturated or unsaturated, C3 to C30, especially C3 to C12; or a C 6 to C 10 aryl radical, X represents a radical selected from the groups: ## STR1 ## where R 1, R 2 and R 3 represent, independently of one another, a hydrogen atom, or radical R, with R as defined above, and R1 'represents a hydrogen atom, a group OH or a radical R as defined above, R1 may also denote a C6 to C10 aryl radical, - S represents a monosaccharide or a polysaccharide having up to 20 sugar units, in particular up to 6 sugar units, in pyranose and / or furanose and L and / or D series form, said mono- or polysaccharide being capable of being substituted by a group hydroxyl which is necessarily free, and optionally one or more optionally protected amine function (s), and the S-CH 2 -X bond represents a C-anomeric bond, which may be a or 13, thus that their cosmetically acceptable salts, their solvates such as the hydrates es and their isomers.  In the context of the present invention, halogen means chlorine, fluorine, bromine or iodine.  The term aryl denotes an aromatic ring such as phenyl, optionally substituted by one or more C1-C4 alkyl radicals.  The term C3-C8 cycloalkyl refers to an aliphatic ring having 3 to 8 carbon atoms, including, for example, cyclopropyl, cyclopentyl and cyclohexyl.  Among the alkyl groups suitable for the implementation of the invention, there may be mentioned especially the methyl, ethyl, isopropyl, n-propyl, n-butyl, t-butyl, isobutyl, sec-butyl and pentyl groups. hexyl, cyclopropyl, cyclopentyl, cyclohexyl, and allyl.  According to one embodiment of the invention, it is possible to use a C-glycoside derivative corresponding to formula (I) for which S can represent a monosaccharide or a polysaccharide containing up to 6 sugar units, in pyranose and / or furanose form. and L and / or D series, said mono- or polysaccharide having at least one hydroxyl function necessarily free and / or optionally one or more amine functions compulsorily protected, X and R otherwise retaining all of the previously given definitions.  Advantageously, a monosaccharide of the invention may be selected from D-glucose, D-galactose, D-mannose, D-xylose, D-lyxose, L-fucose, L-arabinose, L -rhamnose, D-glucuronic acid, D-galacturonic acid, D-iduronic acid, N-acetyl-D-glucosamine, N-acetyl-D-galactosamine and advantageously denotes D-glucose, D-xylose, N-acetyl-D-glucosamine or L-fucose, and in particular D-xylose.  More particularly, a polysaccharide of the invention containing up to 6 sugar units may be selected from D-maltose, D-lactose, D-cellobiose, D-maltotriose, a disaccharide associating a uronic acid selected from D-iduronic acid or D-glucuronic acid with a hexosamine selected from D-galactosamine, D-glucosamine, N-acetyl-D-galactosamine, N-acetyl-D-glucosamine, an oligosaccharide containing at least minus a xylose which can be advantageously chosen from xylobiose, methyl- (3-xylobioside, xylotriose, xylotetraose, xylopentaose and xylohexaose and in particular xylobiose which is composed of two xylose molecules linked by a 1-4 bond .  More particularly, S may represent a monosaccharide selected from D-glucose, D-xylose, L-fucose, D-galactose, D-maltose and especially D-xylose.  According to another embodiment of the invention, it is possible to use C-glycoside derivatives corresponding to formula (I) for which X represents a group chosen from -CO-, -CH (OH) -, -CH (NR1R2 ) -, -CH (R) -, especially -CO-, -CH (OH) -, -CH (NH2) -, -CH (NHCH2CH2CH2OH) -, -CH (NHPh) -, -CH (CH3) -, and more particularly a group -CO-, -CH (OH) -, -CH (NH2) -, and preferably a group -CH (OH) -, S and R otherwise retaining all the definitions 10 previously given.  According to another embodiment of the invention, it is possible to use a C-glycoside derivative corresponding to formula (I) for which R represents a linear, saturated C 1 to C 20, in particular C 1 to C 10, alkyl radical, or unsaturated C2 to C20, in particular C2 to C10, or a branched or cyclic alkyl radical, saturated or unsaturated, C3 to C20; in particular at C3 to C10, and optionally substituted as previously described, S and R also retaining all the definitions previously given.  Preferably, R denotes a linear radical C1-C4, in particular C1-C3, optionally substituted with OH, -COOH or ùCOOR "2, R" 2 being a saturated alkyl radical C1-C4, especially ethyl.  Preferentially, R denotes an unsubstituted linear C1-C4, in particular C1-C2, alkyl radical, in particular ethyl.  Among the C-glycoside derivatives of formula (I), use is preferably made of those for which: R represents a linear, saturated C 1 to C 20, in particular C 1 to C 10, or unsaturated C 2 to C 20 alkyl radical, in particular C2 to C10, or a branched or cyclic alkyl radical, saturated or unsaturated, C3 to C20; in particular C3 to C10, and optionally substituted as described above; S represents a monosaccharide as previously described; X represents -CO-, -CH (OH) -, -CH (NR1R2) -, -CH (R) -as described previously.  Preferably, a C-glycoside derivative of formula (I) is used, for which: R represents a linear C1-C4 radical, in particular C1-C3, optionally substituted with OH, COOH or -COOR "2, R" 2 being a saturated C1-C4 alkyl radical, especially ethyl; S represents a monosaccharide as previously described; X represents a group selected from CO-, -CH (OH) -, -CH (NH2) -, -CH (NHCH2CH2CH2OH) -, -CH (NHPh) -, -CH (CH3) -, and more particularly a grouping ùCO-, -CH (OH) -, -CH (NH2) -, and preferably a group - CH (OH) -.  Preferably, a C-glycoside derivative of formula (I) is used for which - R denotes an unsubstituted linear C1-C4, especially C1-C2 alkyl radical, in particular ethyl; S represents a monosaccharide as previously described; Especially D-glucose, D-xylose, N-acetyl-D-glucosamine or L-fucose, and especially D-xylose; X represents a group chosen from -CO-, -CH (OH) -, -CH (NH 2) -, and preferably a group -CH (OH) -.  Salts acceptable for non-therapeutic use of the compounds described in the present invention include conventional non-toxic salts of said compounds such as those formed from organic or inorganic acids.  By way of example, mention may be made of the salts of mineral acids, such as sulfuric acid, hydrochloric acid, hydrobromic acid, hydroiodic acid, phosphoric acid and boric acid.  There may also be mentioned organic acid salts, which may include one or more carboxylic acid, sulfonic acid, or phosphoric acid groups.  It may be linear, branched or cyclic aliphatic acids or aromatic acids.  These acids may furthermore comprise one or more heteroatoms chosen from O and N, for example in the form of hydroxyl groups.  These include propionic acid, acetic acid, terephthalic acid, citric acid and tartaric acid.  When the compound of formula (I) has an acid group, the neutralization of the acid group (s) can be carried out with a mineral base, such as LiOH, NaOH, KOH, Ca (OH) 2, NH 4 OH, Mg (OH) 2 or Zn (OH) 2; or with an organic base such as a primary, secondary or tertiary alkylamine, for example triethylamine or butylamine.  This primary, secondary or tertiary alkylamine may comprise one or more nitrogen and / or oxygen atoms and may therefore comprise, for example, one or more alcohol functions; mention may in particular be made of 2-amino-2-methylpropanol, triethanolamine, dimethylamino-2-propanol and 2-amino-2- (hydroxymethyl) -1,3-propanediol.  Mention may also be made of lysine or 3- (dimethylamino) propylamine.  Acceptable solvates for the compounds described in the present invention include conventional solvates such as those formed in the last step of preparing said compounds due to the presence of solvents.  By way of example, mention may be made of solvates due to the presence of water or linear or branched alcohols, such as ethanol or isopropanol.  Among the C-glycoside derivatives of formula (I), used according to the invention, the following are particularly considered:  C- (3-D-xylopyranoside-n-propan-2-one;  C-α-D-xylopyranoside-n-propan-2-one; 3.  1- [2- (3-Hydroxypropylamino) propyl] -C- (3-D-xylopyranose);  1- [2- (3-hydroxypropylamino) propyl] -C-α-D-xylopyranose 5.  C- (3-D-xylopyranoside-2-hydroxypropane; 6.  C-α-D-xylopyranoside-2-hydroxypropane; 20 7.  C- (3-D-xylopyranoside-2-amino-propane; 8.  C-α-D-xylopyranoside-2-aminopropane; 9.  C-13-D-xylopyranoside-2-phenylamino propane; 10.  C-α-D-xylopyranoside-2-phenylamino propane; 11.  3-methyl-4- (C- (3-D-xylopyranoside) -butyric acid ethyl ester;  3-methyl-4- (C-α-D-xylopyranoside) -butyric acid ethyl ester; 13.  6- (C- (3-D-xylopyranoside) -5-keto hexanoic acid;  6- (C-α-D-xylopyranoside) -5-keto hexanoic acid; 15.  6- (C- (3-D-xylopyranoside) -5-hydroxy-hexanoic acid;  6- (C-α-D-xylopyranoside) -5-hydroxy-hexanoic acid; 30 17.  6- (C- (3-D-xylopyranoside) -5-aminohexanoic acid;  6- (C-α-D-xylopyranoside) -5-aminohexanoic acid; 19.  6- (C- (3-D-xylopyranoside) -5-phenylaminohexanoic acid;  6- (C-α-D-xylopyranoside) -5-phenylamino-hexanoic acid; 2903008 39 21.  1- (C-β-D-xylopyranoside) -hexane-2,6-diol; 22.  1- (C-α-D-xylopyranoside) -hexane-2,6-diol; 23.  5- (C-β-D-xylopyranoside) -4-keto-pentanoic acid; 24.  5- (C-α-D-xylopyranoside) -4-keto-pentanoic acid; 25.  5- (C- (3-D-xylopyranoside) -4-hydroxy-pentanoic acid;  5- (C-α-D-xylopyranoside) -4-hydroxy-pentanoic acid; 27.  5- (C- (3-D-xylopyranoside) -4-amino-pentanoic acid; 28.  5- (C-α-D-xylopyranoside) -4-amino-pentanoic acid; 29.  5- (C- (3-D-xylopyranoside) -4-phenylaminopentanoic acid;  5- (C-α-D-xylopyranoside) -4-phenylaminopentanoic acid; 31.  1- (C- (3-D-xylopyranoside) -pentane-2,5-diol;  1- (C-α-D-xylopyranoside) -pentane-2,5-diol; 33.  1- (C-13-D-fucopyranoside) -propan-2-one; 34.  1- (C-α-D-fucopyranoside) -propan-2-one; 35.  1- (C-β-L-fucopyranoside) -propan-2-one; 36.  1- (C-α-L-fucopyranoside) -propan-2-one; 37.  1- (C- (3-D-fucopyranoside) -2-hydroxypropane;  1- (C-α-D-fucopyranoside) -2-hydroxypropane; 39.  1- (C-L-fucopyranoside) -2-hydroxypropane; 20 40.  1- (C-α-L-fucopyranoside) -2-hydroxypropane; 41.  1- (C- (3-D-fucopyranoside) -2-amino-propane; 42.  1- (C-α-D-fucopyranoside) -2-amino-propane; 43.  1- (C- (3-L-fucopyranoside) -2-amino-propane;  1- (C-α-L-fucopyranoside) -2-amino-propane; 25 45.  1- (C-D-fucopyranoside) -2-phenylamino propane; 46.  1- (C-α-D -fucopyrano side) -2-phenylamino propane; 47.  1- (C- (3-L-fucopyranoside) -2-phenylamino propane; 48.  1- (C-α-L-fucopyranoside) -2-phenylamino propane; 49.  3-methyl-4- (C- (3-D-fucopyranoside) -butyric acid ethyl ester;  3-methyl-4- (C-α-D-fucopyranoside) -butyric acid ethyl ester; 51.  3-methyl-4- (C-O-L-fucopyranoside) -butyric acid ethyl ester; 2903008 52.  3-methyl-4- (C-α-L-fucopyranoside) -butyric acid ethyl ester; 53.  6- (C-3-D-fucopyranoside) -5-keto hexanoic acid; 54.  6- (C-α-D-fucopyranoside) -5-keto hexanoic acid; 55.  6- (C- (3-L-fucopyranoside) -5-keto hexanoic acid;  6- (C-α-L-fucopyranoside) -5-keto hexanoic acid; 57.  6- (C- (3-D-fucopyranoside) -5-hydroxy-hexanoic acid;  6- (C-α-D-fucopyranoside) -5-hydroxy-hexanoic acid; 59.  6- (C- (3-L-fucopyranoside) -5-hydroxy-hexanoic acid;  6- (C-α-L-fucopyranoside) -5-hydroxy-hexanoic acid; 10 61.  6- (C- (3-D-fucopyranoside) -5-aminohexanoic acid;  6- (C-α-D-fucopyranoside) -5-aminohexanoic acid; 63.  6- (C- (3-L-fucopyranoside) -5-aminohexanoic acid, 64.  6- (C-α-L-fucopyranoside) -5-aminohexanoic acid; 65.  1- (C-13-D-fucopyranoside) -hexane-2,6-diol; 15 66.  1- (C-α-D-fucopyranoside) -hexane-2,6-diol; 67.  1- (C- (3-L-fucopyranoside) -hexane-2,6-diol;  1- (C-α-L-fucopyranoside) -hexane-2,6-diol; 69.  5- (C- (3-D-fucopyranoside) -4-keto-pentanoic acid; 70.  5- (C-α-D-fucopyranoside) -4-keto-pentanoic acid; 20 71.  5- (C- (3-L-fucopyranoside) -hexane-2,6-diol) -4-keto-pentanoic acid; 72.  5- (C-α-L-fucopyranoside) -hexane-2,6-diol) -4-keto-pentanoic acid; 73.  5- (C-13-D-fucopyranoside) -4-hydroxy-pentanoic acid; 74.  5- (C-α-D-fucopyranoside) -4-hydroxy-pentanoic acid; 75.  5- (C-β-L-fucopyranoside) -4-hydroxy-pentanoic acid; 25 76.  5- (C-α-L-fucopyranoside) -4-hydroxy-pentanoic acid; 77.  5- (C- (3-D-fucopyranoside) -4-amino-pentanoic acid; 78.  5- (C-α-D-fucopyranoside) -4-amino-pentanoic acid 79.  5- (C- (3-L-fucopyranoside) -4-amino-pentanoic acid;  5- (C-α-L-fucopyranoside) -4-amino-pentanoic acid; 30 81.  1- (C- (3-D-fucopyranoside) -pentane-2,5-diol; 82.  1- (C-α-D-fucopyranoside) -pentane-2,5-diol; 2903008 41 83.  1- (C- (3-L-fucopyranoside) -pentane-2,5-diol;  1- (C-α-L-fucopyranoside) -pentane-2,5-diol; 85.  1- (C- (3-D-glucopyranosyl) -2-hydroxypropane; 86.  1- (C-α-D-glucopyranosyl) -2-hydroxypropane; 5 87.  1- (C-13-D-glucopyranosyl) -2-amino-propane; 88.  1- (C-α-D-glucopyranosyl) -2-amino-propane; 89.  1- (C-β-D-glucopyranosyl) -2-phenylaminopropane; 90.  1- (C-α-D-glucopyranosyl) -2-phenylamino propane; 91.  3-methyl-4- (C- (3-D-glucopyranosyl) -butyric acid ethyl ester;  3-methyl-4- (C-α-D-glucopyranosyl) -butyric acid ethyl ester; 93.  6- (C- (3-D-glucopyranosyl) -5-keto hexanoic acid;  6- (C-α-D-glucopyranosyl) -5-keto hexanoic acid; 95.  6- (C- (3-D-glucopyranosyl) -5-hydroxy-hexanoic acid; 96.  6- (C-α-D-glucopyranosyl) -5-hydroxy-hexanoic acid; 15 97.  6- (C- (3-D-glucopyranosyl) -5-aminohexanoic acid; 98.  6- (C-α-D-glucopyranosyl) -5-aminohexanoic acid; 99.  6- (C- (3-D-glucopyranosyl) -5-phenylamino-hexanoic acid;  6- (C-α-D-glucopyranosyl) -5-phenylamino-hexanoic acid; 101.  1- (C- (3-D-glucopyranosyl) hexane-2,6-diol; 102.  1- (C-α-D-glucopyranosyl) hexane-2,6-diol; 103.  6- (C- (3-D-glucopyranosyl) -5-keto-pentanoic acid;  6- (C-α-D-glucopyranosyl) -5-keto-pentanoic acid; 105.  6- (C-13-D-glucopyranosyl) -5-hydroxy-pentanoic acid; 106.  6- (C-α-D-glucopyranosyl) -5-hydroxy-pentanoic acid; 25 107.  6- (C-β-D-glucopyranosyl) -5-amino-pentanoic acid; 108.  6- (C-α-D-glucopyranosyl) -5-hydroxy-pentanoic acid; 109.  6- (C- (3-D-glucopyranosyl) -5-phenylaminopentanoic acid;  6- (C-α-D-glucopyranosyl) -5-phenylaminopentanoic acid; 111.  1- (C- (3-D-glucopyranosyl) -pentane-2,5-diol;  1- (C-α-D-glucopyranosyl) -pentane-2,5-diol; 113.  1- (C- (3-D-galactopyranosyl) -2-hydroxypropane; 2903008 42,114.  1- (C-α-D-galactopyranosyl) -2-hydroxypropane; 115.  1- (C- (3-D-galactopyranosyl) -2-amino-propane;  1- (C-α-D-gal actopyranosyl) -2-amino-propane; 117.  1- (C- (3-D-galactopyranosyl) -2-phenylamino-propane;  1- (Ca-D-galactopyrano-syl) -2-phenylamino-propane; 119.  3-methyl-4 - ((3-D-galactopyranosyl) -butyric acid ethyl ester;  3-methyl-4- (α-D-galactopyranosyl) -butyric acid ethyl ester; 121.  6- (C- (3-D-galactopyranosyl) -5-keto-hexanoic acid;  6- (C-α-D-galactopyranosyl) -5-keto hexanoic acid; 10 123.  6- (C- (3-D-galactopyranosyl) -5-hydroxy-hexanoic acid;  6- (C-α-D-galactopyranosyl) -5-hydroxy-hexanoic acid; 125.  6- (C- (3-D-galactopyranosyl) -5-aminohexanoic acid;  6- (C-α-D-galactopyranosyl) -5-aminohexanoic acid; 127.  6- (C- (3-D-galactopyranosyl) -5-phenylamino-hexanoic acid; 128.  6- (C-α-D-galactopyranosyl) -5-phenylamino-hexanoic acid; 129.  1- (C- (3-D-galactopyranosyl) hexane-2,6-diol;  1- (C-α-D-galactopyrano-syl) -hexane-2,6-diol; 131.  6- (C- (3-D-galactopyranosyl) -5-keto-pentanoic acid;  6- (C-α-D-galactopyranosyl) -5-keto-pentanoic acid; 133.  6- (C- (3-D-galactopyranosyl) -5-hydroxy-pentanoic acid; 134.  6- (C-α-D-galactopyranosyl) -5-hydroxy-pentanoic acid; 135.  6- (C- (3-D-galactopyranosyl) -5-amino-pentanoic acid;  6- (C-α-D-galactopyranosyl) -5-amino-pentanoic acid; 137.  6- (C- (3-D-galactopyranosyl) -5-phenylaminopentanoic acid; 138.  6- (C-α-D-galactopyranosyl) -5-phenylaminopentanoic acid; 139.  1- (C-D-galactopyranosyl) -pentane-2,6-diol; 140.  1- (C-α-D-galactopyranosyl) -pentane-2,6-diol; 141.  1- (C-13-D-fucofuranosyl) propan-2-one; 142.  1- (C-α-D-fucofuranosyl) propan-2-one; 143.  1- (C- (3-L-fucofuranosyl) propan-2-one;  1- (C-a-L-fuco furano-syl) -propan-2-one; 2903008 43 145.  3 '- (acetamido-C43-D-glucopyranosyl) -propan-2'-one; 146.  3 '- (acetamido-C-α-D-glucopyranosyl) propan-2'-one; 147.  1 - (acetamido-C- (3-D-glucopyranosyl) -2-hydroxylpropane; 148.  1- (acetamido-C-D-glucopyranosyl) -2-amino-propane; 5 149.  1- (acetamido-C-D-glucopyranosyl) -2-phenylamino propane; 150.  1- (acetamido-C-α-D-glucopyranosyl) -2-phenylamino propane; 151.  3-methyl-4- (acetamido-C-3-D-glucopyranosyl) butyric acid ethyl ester; 152.  3-methyl-4- (acetamido-C-α-D-glucopyranosyl) butyric acid ethyl ester; 153.  6- (acetamido-C- (3-D-glucopyranosyl) -5-keto hexanoic acid;  6- (acetamido-C-α-D-glucopyranosyl) -5-keto hexanoic acid; 155.  6- (acetamido-C- (3-D-glucopyranosyl) -5-hydroxy-hexanoic acid;  6- (acetamido-C-α-D-glucopyranosyl) -5-hydroxy-hexanoic acid; 15 157.  6- (acetamido-C- (3-D-glucopyranosyl) -5-aminohexanoic acid;  6- (acetamido-C-α-D-glucopyranosyl) -5-aminohexanoic acid; 159.  6- (acetamido-C- (3-D-glucopyranosyl) -5-phenylamino-hexanoic acid;  6- (acetamido-C-α-D-glucopyranosyl) -5-phenylamino-hexanoic acid; 161.  1- (acetamido-C-β-D-glucopyranosyl) hexane-2,6-diol; 20 162.  1- (acetamido-C-α-D-glucopyranosyl) hexane-2,6-diol; 163.  6- (acetamido-C- (3-D-glucopyranosyl) -5-keto-pentanoic acid;  6- (acetamido-C-α-D-glucopyranosyl) -5-keto-pentanoic acid; 165.  6- (acetamido-C- (3-D-glucopyranosyl) -5-hydroxy-pentanoic acid;  6- (acetamido-C-α-D-glucopyranosyl) -5-hydroxypentanoic acid; 25 167.  6- (acetamido-C-D-glucopyranosyl) -5-aminopentanoic acid; 168.  6- (acetamido-C-α-D-glucopyranosyl) -5-aminopentanoic acid; 169.  6- (acetamido-C-13-D-glucopyranosyl) -5-phenylaminopentanoic acid; 170.  6- (acetamido-C-α-D-glucopyranosyl) -5-phenylaminopentanoic acid; 171.  1- (acetamido-C- (3-D-glucopyranosyl) -pentane-2,5-diol; 172.  1 (acetyl-C-α-D-glucopyranosyl) -pentane-2,5-diol.  By way of non-limiting illustration of the C-glycoside derivatives which are more particularly suitable for the invention, mention may be made especially of the following derivatives: C-13-D-xylopyranoside-n-propan-2-one, CaD -xylopyranoside-n-propan-2-one, 5 - C- (3-D-xylopyranoside-2-hydroxypropane, - CaD-xylopyranoside-2-hydroxypropane, 1- (C-f3-) D-fucopyranoside) -propan-2-one, 1- (CaD-fucopyranoside) -propan-2-one, 1- (C- (3-L-fucopyranoside) -propan-2-one, 1 - (α-L-fucopyranoside) -propan-2-one, 1- (C- (3-D-fucopyranoside) -2-hydroxy-propane, 1- (CaD-fucopyranoside) -2-hydroxypropane, - 1- (C- (3-L-fucopyranoside) -2-hydroxy-propane, 1- (CaL-fucopyranoside) -2-hydroxy-propane, 1- (C- (3-D-glucopyranosyl) - 2-hydroxylpropane, 1- (CaD-glucopyranosyl) -2-hydroxylpropane, 1- (C- (3-D-galactopyranosyl) -2-hydroxylpropane, 1- (CaD-galactopyranosyl) 2-hydroxy-propane 1- (C-β-D-fucofuranosyl) -propan-2-one, 1- (CaD-fucofuranosyl) 1) -propan-2-one 1- (C- (3-L-fucofuranosyl) -propan-2-one, 1- (CaL-fucofuranosyl) -propan-2-one, C- (3- D-maltopyranoside-n-propan-2-one, CaD-maltopyranoside-n-propan-2-one, C- (3-D-maltopyranoside-2-hydroxy-propane, CaD-maltopyranoside-2-hydroxy- propane, their isomers and mixtures thereof.  According to one embodiment, C- (3-D-xylopyranoside-2-hydroxy-propane or CaD-xylopyranoside-2-hydroxypropane, and more preferably C- (3-D-xylopyranoside-2-hydroxy- propane can advantageously be used for the preparation of a composition according to the invention.  According to one particular embodiment, the C-glycoside derivative is C- (3-D-xylopyranoside-2-hydroxy-propane in the form of a solution containing 30% by weight of active material in a water / propylene glycol mixture ( 60/40% by weight) such as the product manufactured by CHIMEX under the trade name MEXORYL SBB. Of course, according to the invention, a C-glycoside derivative corresponding to formula (I) can be used alone or in admixture with other C-glycoside derivatives and in any proportion.  A C-glycoside derivative that is suitable for the invention may in particular be obtained by the synthesis method described in WO 02/051828.  The amount of C-glycoside derivative to be used in a composition according to the invention depends on the desired cosmetic or therapeutic effect, and can therefore vary to a large extent.  Those skilled in the art can easily, on the basis of their general knowledge, determine the appropriate amounts.  A composition according to the invention may comprise a C-glycoside derivative in a proportion of about 0.0001% to about 25% by weight of active material relative to the total weight of the composition, and in particular of about 0.001% to about 10% by weight of active material, and more particularly from about 0.05% to about 5% by weight of active C-glycoside derivative relative to the total weight of the composition.  ADDITIONAL COMPOUNDS The compositions in accordance with the invention may additionally comprise other additional organic photoprotective agents active in UV-A and / or UV-B that are hydrophilic or lipophilic in the cosmetic solvents commonly used.  The additional organic photoprotective agents are in particular chosen from anthranilates; cinnamic derivatives; salicylic derivatives, camphor derivatives; benzophenone derivatives; derivatives of (3, (3-diphenylacrylate; triazine derivatives; benzotriazole derivatives; benzalmalonate derivatives, in particular those cited in US Pat. No. 5,624,663; benzimidazole derivatives; imidazolines; bis-benzoazolyl derivatives such as described in patents EP 669 323 and US 2,463,264, derivatives of p-aminobenzoic acid (PABA), benzoxazole derivatives as described in patent applications EP 0 832 642, EP 1 027 883, EP 1 300 137 and DE 10 162 844, filter and silicone screening polymers such as those described in particular in the application WO-93/04665, the dimers derived from α-alkylstyrene such as those described in the patent application DE 19 855 649; 4,4-diarylbutadienes as described in EP 0 967 200, DE 19 746 654, DE 19 755 649, EP-A-1 008 586, EP 1 133 980 and EP 133 981 and mixtures thereof.  As examples of complementary organic photoprotective agents, mention may be made of those designated below under their INCI name: Derivatives of para-aminobenzoic acid: PABA, Ethyl PABA, Ethyl Dihydroxypropyl PABA, Ethylhexyl Dimethyl PABA sold in particular under the name ESCALOL 507 by ISP, Glyceryl PABA, PEG-25 PABA sold under the name Uvinul P25 by BASF, Derivatives of dibenzoylmethane: Butyl Methoxydibenzoylmethane sold in particular under the trade name Parsol 1789 by Hoffmann Laroche, Isopropyl Dibenzoylmethane, Salicylic derivatives: Homosalate sold under the name Eusolex HMS by Rona / EM Industries, Ethylhexyl Salicylate sold under the name NEO HELIOPAN OS by Haarmann and REIMER, Dipropylene glycol salicylate sold under the name DIPSAL by SCHER, TEA Salicylate, sold under the name NEO HELIOPAN TS by Haarmann and 30 REIMER, Cinnamic derivatives: Ethylhexyl methoxycinnamate sold in particular under the trade name PARSOL MCX by HOF FMANN LA ROCHE, Isopropyl Methoxy cinnamate, Isoamyl Methoxy cinnamate sold under the trade name NEO HELIOPAN E 1000 by HAARMANN and REIMER, Cinoxate, DEA Methoxycinnamate, Diisopropyl Methylcinnamate, Glyceryl Ethylhexanoate Dimethoxycinnamate, Derivatives of 3J3-diphenylacrylate: Octocrylene sold in particular under trade name UVINUL N539 by BASF, Etocrylene sold in particular under the trade name UVINUL N35 by BASF, Derivatives of benzophenone: Benzophenone-1 sold under the trade name UVINUL 400 by BASF, 20 Benzophenone-2 sold under the trade name UVINUL D50 by BASF, Benzophenone-3 or Oxybenzone, sold under the trade name UVINUL M40 by BASF, Benzophenone-4 sold under the trade name UVINUL MS40 by BASF, Benzophenone-5, Benzophenone-6 sold under the trade name Helisorb 11 by Norquay, Benzophenone -8 sold under the trade name Spectra-Sorb UV-24 by American Cyanamid, Benzophenone-9 sold under the trade name U VINUL DS-49 by BASF, Benzophenone-12, n-hexyl 2- (4-diethylamino-2-hydroxybenzoyl) benzoate, 2903008 Benzylidene camphor derivatives: 3-Benzylidene camphor manufactured under the name MEXORYL SD by CHIMEX, 4-Methylbenzylidene camphor sold under the name Eusolex 6300 by Merck, Benzylidene Camphor Sulfonic Acid manufactured under the name Mexoryl SL by Chimex, Camphor Benzalkonium Methosulfate manufactured under the name Mexoryl 10 by Chimex, Terephthalylidene Dicamphor Sulfonic Acid manufactured under the name Mexoryl SX by CHIMEX, Polyacrylamidomethyl Benzylidene Camphor manufactured under the name MEXORYL SW by CHIMEX, 15 Derivatives of phenyl benzimidazole: Phenylbenzimidazole Sulfonic Acid sold in particular under the trade name Eusolex 232 by Merck, Disodium Phenyl Dibenzimidazole Tetra-sulphonate sold under the name commercial 20 NEO HELIOPAN PA by Haarmann and REIMER, Derivatives of phenyl benzotriazole: Drometrizole Trisiloxane sold under the name Silatrizole by RHODIA CHIMIE, Triazine derivatives: 2,4,6-tris (dineopentyl 4'-amino benzalmalonate) -s-triazine, 2,4,6-tris- (4'-amino benzalmalonate diisobutyl) - s-triazine, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine sold under the trade name TINOSORB S by CIBA GEIGY, Ethylhexyl triazone sold in particular under the trade name UVINUL T150 by BASF, 2903008 49 Diethylhexyl Butamido Triazone sold under the trade name UVASORB HEB by SIGMA 3V, Anthranilic derivatives: Menthyl anthranilate sold under the trade name NEO HELIOPAN MA by Haarmann and REIMER, Imidazoline derivatives: Ethylhexyl Dimethoxybenzylidene Dioxoimidazoline Propionate, Derivatives of benzalmalonate: Di-neopentyl 4'-methoxybenzalmalonate, Polyorganosiloxane with benzalmalonate functions such as Polysilicone Sold under the trade name PARSOL SLX by HOFFMANN LA ROCHE, Derivatives of 4,4-diarylbutadiene: -1,1-dicarboxy (2,2'-dim ethyl-propyl) -4,4-diphenylbutadiene, benzoxazole derivatives: 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) imino] -6- (2-ethylhexyl) ) -imino-1,3,5-triazine sold under the name UV-Asorb K2A by Sigma 3V, and mixtures thereof.  Preferred complementary organic photoprotective agents are selected from: Ethylhexyl Methoxycinnamate, Butyl Methoxydibenzoylmethane, Homosalate, Ethylhexyl Salicylate, Octocrylene, Phenylbenzimidazole Sulfonic Acid, Benzophenone-3, 2903008 Benzophenone-4, Benzophenone-5, 2- (4-diethylamino-2) n-hexylbenzoyl) -benzoate, 4-Methylbenzylidene camphor, Terephthalylidene Dicamphor Sulfonic Acid, Disodium Phenyl Dibenzimidazole Tetrasulfonate, Ethylhexyl Triazone, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine, Diethylhexylbutamido Triazone, 2,4,6-Tris ( Dineopentyl 4'-amino benzalmalonate) -s-triazine, Drometrizole Trisiloxane, Di-neopentyl 4'-methoxybenzalmalonate, Polysilicone-15,1,1-dicarboxy (2,2'-dimethyl-propyl) -4,4-diphenylbutadiene, 2,4-bis- [5-1 (dimethylpropyl) benzoxazol-2-yl- (4-phenyl) imino] -6 (2-ethylhexyl) imino-1,3,5-triazine, and mixtures thereof.  The compositions according to the invention may further comprise other inorganic photoprotective agents.  The additional photoprotective agents are generally present in the compositions according to the invention in proportions ranging from 0.01% to 20% by weight relative to the total weight of the composition, and preferably ranging from 0.1% to 10% by weight relative to the total weight of the composition. Relative to the total weight of the composition.  COMPOSITION The compositions according to the invention may be in any form suitable for topical application, especially in the form of aqueous gels, in the form of emulsions obtained by dispersion of a fatty phase (also called oily phase) in one phase. aqueous (oil-in-water O / W emulsion) or conversely (water-in-oil W / O emulsion) or multiple emulsions (for example W / O / W or W / O / H or H / H / W) ) nanoemulsions, oleosomes.  They may be more or less fluid and have the appearance of a white or colored cream, an ointment, a milk, a lotion, a serum, an oil, a paste, powder, solid stick and optionally be packaged in aerosol and be in the form of foam or spray, or impregnated fabric (such as wipes).  These compositions are prepared according to the usual methods.  According to a particular embodiment of the invention, the composition according to the invention is in the form of an emulsion and then comprises at least one oily phase.  The proportion of the oily phase of the emulsion can range from 1 to 80% by weight, preferably from 2 to 50% by weight and better still from 2 to 40% by weight relative to the total weight of the composition.  The fatty substances of the oily phase, in particular the oils, and the emulsifiers and co-emulsifiers that may be present, used in the composition in emulsion form are chosen from those conventionally used in the cosmetic or dermatological field.  The emulsifier and the co-emulsifier, when present, are generally present in a proportion of from 0.1 to 30% by weight, preferably from 0.3 to 20% by weight and more preferably 0.5% by weight. to 15% by weight relative to the total weight of the composition.  The emulsion may further contain lipid vesicles in addition to or in place of emulsifiers and / or co-emulsifiers.  The emulsions generally contain at least one emulsifier chosen from amphoteric, anionic, cationic or nonionic emulsifiers used alone or as a mixture.  The emulsifiers are suitably selected according to the continuous phase of the emulsion to be obtained (W / O or O / W).  When the emulsion is multiple, it generally comprises an emulsifier in the primary emulsion and an emulsifier in the external phase into which the primary emulsion is introduced.  Exemplary emulsifiers for the preparation of W / O emulsions include, for example, alkyl esters or ethers of sorbitan, glycerol or sugars; silicone surfactants such as dimethicone copolyols such as the mixture of cyclomethicone and dimethicone copolyol, sold under the names DC 5225 C and DC 3225 C by the company Dow Corning, and as alkyl dimethicone copolyols such as Laurylmethicone copolyol sold under the name Dow Corning 5200 formulation, Dow Corning Formulation Aid, Cetyl dimethicone copolyol sold under the name Abil EM 90 by the company Goldschmidt and the mixture of Polyglyceryl-4 isostearate / Cetyl dimethicone copolyol / Hexyl laurate sold under the name Abil WE 09 over there

  Goldschmidt company. One or more co-emulsifiers may also be added, which advantageously may be selected from the group consisting of branched chain fatty acid esters and polyol, including chain fatty acid esters. branched and glycerol and / or sorbitan and for example polyglyceryl isostearate, such as the product sold under the name Isolan GI 34 by the company Goldschmidt, sorbitan isostearate, such as the product sold under the name Arlacel 987 by the company ICI, sorbitan isostearate and glycerol, such as the product sold under the name Arlacel 986 by the company ICI, and mixtures thereof. As emulsifiers that can be used for the preparation of O / W emulsions, mention may be made, for example, of nonionic emulsifiers such as fatty acid esters of oxyalkylenated polyols (more particularly polyoxyethylenated), and for example polyethylene glycol stearates such as PEG-100 stearate, PEG-50 stearate and PEG-40 stearate; esters of oxyalkylenated fatty acids and of sorbitan comprising, for example, from 20 to 100%, and for example those sold under the trade names Tween 20 or Tween 60 by the company Uniqema; oxyalkylenated fatty alcohol ethers (oxyethylenated and / or oxypropylenated); esters of sugars, alkoxylated or otherwise, such as sucrose stearate and PEG-20 methylglucose sesquistearate; sorbitan esters such as sorbitan palmitate sold under the name Span 40 by Uniqema; diacid and fatty alcohol esters, such as dimyristyl tartrate; mixtures of these emulsifiers, for example the mixture of glyceryl stearate and PEG-100 stearate (CTFA name: Glyceryl Stearate / PEG-100 Stearate) sold under the name Arlacel 165 by Uniqema and under the name SIMULSOL 165 by the company SEPPIC; or the mixture of dimyristyl tartrate, cetearyl alcohol, Pareth-7 and PEG-25 laureth-25, sold under the name Cosmacol PSE by the company Sasol (CTFA name: Dimyristyl tartrate / cetearyl alcohol / 12-15 Pareth 7 / PPG 25 laureth 25). Co-emulsifiers such as, for example, fatty alcohols having from 8 to 26 carbon atoms, such as cetyl alcohol, stearyl alcohol and their mixture (cetearyl alcohol), octyl dodecanol, may be added to these emulsifiers. 2-butyloctanol, 2-hexyldecanol, 2-undecylpentadecanol or oleic alcohol, or fatty acids. It is also possible to prepare emulsions without emulsifying surfactants or containing less than 0.5% of the total weight of the composition, by using suitable compounds for stabilizing said emulsions, for example amphiphilic polymers, fillers, thickeners or gelling agents. . When the composition of the invention is in emulsion form, it comprises at least one oily phase which contains at least one oil, in particular a cosmetic oil. By oil is meant a fatty substance that is liquid at room temperature (25 ° C.). As oils that can be used in the composition of the invention, it is possible to use, for example, hydrocarbon-based oils of animal origin, such as perhydrosqualene (or squalane); hydrocarbon oils of vegetable origin, such as triglycerides of caprylic / capric acids, such as those sold by Stearineries Dubois or those sold under the names Miglyol 810, 812 and 818 by the company Dynamit Nobel, or the oils of origin vegetable oils, for example sunflower, corn, soya, squash, grape seed, sesame, hazelnut, apricot, macadamia, arara, coriander, castor oil, avocado, jojoba oil, shea butter oil; synthetic oils; silicone oils such as volatile or non-volatile polymethylsiloxanes (PDMS) with a linear or cyclic silicone chain, which are liquid or pasty at room temperature; fluorinated oils such as those partially hydrocarbon and / or silicone such as those described in JP-A-2-295912; ethers such as dicaprylic ether (CTFA name: Dicaprylyl ether); and benzoates of C12-C15 fatty alcohols (Finsolv TN of FINETEX); arylalkyl benzoate derivatives such as 2-phenylethyl benzoate (ISP X-Tend 226); amidated oils such as isopropyl N-lauroylsarcosinate (ELDEW SL-205 from Ajimoto) and mixtures thereof. The oily phase may also comprise one or more fatty substances chosen, for example, from fatty alcohols (cetyl alcohol, stearyl alcohol, cetearyl alcohol), fatty acids (stearic acid) or waxes (paraffin wax, polyethylene waxes, carnauba wax). , beeswax). The composition of the invention may contain one or more organic solvents which may be selected from the group consisting of hydrophilic organic solvents, lipophilic organic solvents, amphiphilic solvents or mixtures thereof. Among the hydrophilic organic solvents, mention may be made, for example, of linear or branched monohydric alcohols having from 1 to 8 carbon atoms, such as ethanol, propanol, butanol, isopropanol or isobutanol; polyethylene glycols 2903008 54 having from 6 to 80 ethylene oxides; polyols such as propylene glycol, isoprene glycol, butylene glycol, glycerol, sorbitol; mono- or di-alkyl of isosorbide whose alkyl groups have from 1 to 5 carbon atoms such as dimethyl isosorbide; glycol ethers such as diethylene glycol mono-methyl or mono-ethyl ether and propylene glycol ethers such as dipropylene glycol methyl ether. As amphiphilic organic solvents, mention may be made of polypropylene glycol (PPG) derivatives such as the esters of polypropylene glycol and of fatty acid, of PPG and of fatty alcohol such as PPG-23 oleyl ether and PPG-36 oleate. Lipophilic organic solvents include, for example, fatty esters such as diisopropyl adipate, dioctyl adipate, alkyl benzoates. The compositions in accordance with the present invention may also comprise conventional cosmetic adjuvants chosen from softeners, humectants, opacifiers, stabilizers, emollients, silicones, defoamers, perfumes, preservatives, anionic surfactants and cationic surfactants. nonionic, zwitterionic or amphoteric agents, fillers, polymers, propellants, alkalinizing or acidifying agents or any other ingredient usually used in the cosmetic and / or dermatological field. As hydrophilic thickeners, mention may be made of carboxyvinyl polymers such as carbopols (carbomers) and Pemulen (acrylate / Clo-C30-alkylacrylate copolymer); cellulosic derivatives such as hydroxyethylcellulose; mono- and polysaccharides and especially gums such as xanthan gum; associative polymers and mixtures thereof. As lipophilic thickeners, mention may be made of modified clays such as hectorite and its derivatives, such as the products sold under the name Bentone.

As preservatives, there may be mentioned esters of parahydroxybenzoic acid also called Parabens (in particular methyl paraben, ethyl paraben, propyl paraben), phenoxyethanol, formalin liberators such as, for example, imidazolidinyl urea or diazolidinyl urea, chlorhexidine digluconate, sodium benzoate, caprylyl glycol, iodo propynyl butyl carbamate, pentylene glycol, alkyl trimethylammonium bromide such as myristyltrimethylammonium bromide (CTFA name: Myrtrimonium bromide), dodecyltrimethylammonium bromide, hexadecyltrimethylammonium bromide, and mixtures thereof, such as the mixture sold under the name Cetrimide by FEF CHEMICALS 2903008 and plant derivatives with antimicrobial properties. The preservative may be present in the composition according to the invention in a content ranging from 0.001 to 10% by weight, relative to the total weight of the composition, in particular ranging from 0.1 to 5% by weight, and in particular ranging from 0.2 to 3% by weight.

As fillers which may be used in the composition of the invention, for example, pigments may be mentioned; silica powder; talcum; polyamide particles and in particular those sold under the name ORGASOL by the company Atochem; polyethylene powders; powders of natural organic materials such as starch powders, in particular crosslinked or non-crosslinked corn, wheat or rice starches, such as starch powders crosslinked with octenylsuccinate anhydride, sold under the name DRY-FLO by National Starch; microspheres based on acrylic copolymers, such as those made of ethylene glycol dimethacrylate / lauryl methacrylate copolymer sold by Dow Corning under the name Polytrap; polymethyl methacrylate powders such as those co-commercialized under the name MICROPEARL M 100 by the company Matsumoto; expanded powders such as hollow microspheres and in particular the microspheres sold under the name Expancel by the company Kemanord Plast or under the name Micropearl F 80 ED by the company Matsumoto; silicone resin microbeads such as those sold under the name TOSPEARL by Toshiba Silicone; polyurethane powders such as the hexamethylene diisocyanate / trimethylol hexyllactone copolymer powder marketed under the name Plastic Powder D-400 by the company Toshiba Pigment (CTFA name: HDI / Trimethylol Hexyllactone Crosspolymer); fibers; and their mixtures. When present, these fillers may be in amounts ranging from 0.001 to 20% by weight, preferably from 0.1 to 10% by weight and more preferably from 1 to 5% by weight relative to the total weight of the composition. . Of course, those skilled in the art will take care to choose the optional additional compound (s) mentioned above and / or their amounts in such a way that the advantageous properties intrinsically attached to the combination according to the invention are not excluded. , or substantially not, altered by the addition or additions envisaged. The composition according to the invention is generally suitable for topical application to the skin and comprises a physiologically acceptable medium, that is to say compatible with the skin and / or its integuments.

This physiologically acceptable medium comprises water, optionally mixed or not with one or more organic solvents such as a C 1 -C 8 alcohol, in particular ethanol, isopropanol, tert-butanol, n-butanol and the like. butanol, polyols such as glycerine, propylene glycol, butylene glycol and polyol ethers.

It is preferably a cosmetically acceptable medium, that is to say which has a pleasant color, odor and feel and which does not generate unacceptable discomfort (tingling, tightness, redness), which is susceptible to divert the consumer from using this composition. The composition according to the invention may constitute a product for the care of the skin, in particular for the face, the neck, the contour of the eye, the body; or else a skin makeup product such as a complexion product (especially a foundation), an eyeshadow, a blusher, an eyeliner, a concealer, a makeup product from the skin. body, a sunscreen product or a skin cleanser. Preferably, the composition according to the invention will be a sunscreen product and daily photoprotection. The composition is generally not rinsed, but it can be rinsed if it is a cleaning product including foaming. The subject of the invention is also a process for the cosmetic treatment of a keratin material such as the skin, eyelashes, eyebrows, nails or mucous membranes, characterized in that a composition is applied to the keratinous material. as defined above. According to another aspect, the invention also relates to a cosmetic and / or dermatological assembly comprising: i) a container delimiting at least one compartment, said container being closed by a closure element; and ii) a composition as described above and disposed within said compartment. The container can be in any suitable form. It may in particular be in the form of a bottle, a tube, a pot, a case, a box, a bag or a box. The closure element may be shape of a removable cap, a lid, a lid, a tearable strip, or a capsule, in particular of the type comprising a body attached to the container and a cap hinged to the body. It may also be in the form of an element ensuring the selective closure of the container, in particular a pump, a valve, or a valve. The product can be contained directly in the container, or indirectly. By way of example, the product may be placed on an impregnated support, in particular in the form of a wipe or a tampon, and arranged (in one or more units) in a box or in a bag. Such a support incorporating the product is described for example in the application WO 01/03538. The closure member may be coupled to the container by screwing. Alternatively, the coupling between the closure element and the container is done otherwise than by screwing, in particular via a bayonet mechanism, snap-fastening, clamping, welding, gluing, or magnetic attraction. By snapping is meant in particular any system involving the crossing of a bead or a bead of material by elastic deformation of a portion, in particular of the closure element, then by return to the position not elastically constrained of said portion after crossing the bead or cord. The container may be at least partly made of thermoplastic material. Examples of thermoplastic materials include polypropylene or polyethylene. Alternatively, the container is made of non-thermoplastic material, in particular glass or metal (or alloy). The container may have rigid walls or deformable walls, in particular in the form of a tube or a tube, or sachet. The container may include means for causing or facilitating the dispensing of the composition. By way of example, the container may have walls that are deformable so as to cause the composition to exit in response to an overpressure inside the container, which overpressure is caused by elastic (or non-elastic) crushing of the walls of the container. container. The compositions according to the invention may be in the form of vaporizable fluid lotions according to the invention are applied to the skin or the hair 30 in the form of fine particles by means of pressurizing devices. The devices according to the invention are well known to those skilled in the art and include non-aerosol pumps or atomizers, aerosol containers comprising a propellant as well as aerosol pumps using compressed air as a propellant, or pocket systems. These are described in US Pat. Nos. 4,077,441 and 4,850,517. The aerosol-conditioned compositions according to the invention generally contain conventional propellants such as, for example, hydrofluorinated compounds, dichlorodifluoromethane, difluoroethane, dimethyl ether, isobutane, n-butane, propane and trichlorofluoromethane. They are present preferably in amounts ranging from 15 to 50% by weight relative to the total weight of the composition. The invention will now be described with reference to the following examples given by way of nonlimiting illustration. In these examples, unless otherwise indicated, the amounts are expressed in percentages by weight. EXAMPLES Oil-in-water (O / W) emulsion The C-glycoside derivative used is C-13-D-xylopyranoside-2-hydroxypropane manufactured by Chimex under the trade name MEXORYL SBB. It is in the form of a 30% solution by weight of active material in a water / propylene glycol 60/40 mixture. Formula Formula Formula Formula Formula Formula Formula Compositions 1 2 3 4 5 6 7 PHASE A Poly Dimethylsiloxane 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Preservatives 1 1 1 1 1 1 1 Stearic Acid 1,5 1,5 1,5 1,5 1,5 1,5 1,5 1 1 1 1 1 1 1 glyceryl mono-stearate / PEG stearate (100 EO) mixture C12 / C15 alcohol benzoate 5 - 5 - - - Butyl 2 2.5 2 2 2 2 2 Methoxydibenzoylmethane Octocrylene, Drometrizole Trisiloxane 1 1 4 1 Bis-Ethylhexyloxyphenol 1 3 1 3 3 3 Methoxyphenyl Triazine Methylene bis-10 10 10 10 benzotriazolyl tetramethylbutylphenol Titanium dioxide 3 5 5 5 Ethylhexyl 3 5 5 5 Methoxycinnamate Iso-Hexadecane 1 1 1 1 1 1 1 Cetyl alcohol 0.5 0.5 0.5 0.5 0.5 0.5 0.5 Mixture of cetylstearyl 2 2 2 2 2 2 2 glucoside and cetyl alcohols, stearyl Phase B Deionized water qs 100 qs 100 qs 100 qs 100 qs 100 qs 100 qs 100 Complex 0.1 0.1 0.1 0 , 1 0.1 0.1 0.1 C- (3-D-xylopyranoside-2 - 3 6 3 3 6 6 6 hydroxypropane in 0.9) (1.8) (0.9) (0.9) (1.8) (1.8) (1.8) 30% solution by weight in a water / propylene glycol 60/40 mixture (C-glycoside in MA) Glycerol 5 5 5 5 5 5 Xanthan gum 0.2 0.2 0.2 0.2 0.2 0.2 0.2 Terephthalylidene-0.5 0.5 0.75 0.75 0.5 0.5 0.5 dicamphor disulfonic acid (as MA) Phase C Acid Copolymer 0.2 0.2 0.2 0.2 0.2 0.2 0.2 acrylic / stearyl methacrylate Triethanolamine 0.65 0.65 0.65 0.65 0.65 0.65 0.65 MA: active ingredient Procedure 5 The aqueous phase (Phase B) containing all its ingredients is heated to 80 ° C. in a water bath . The fatty phase (Phase A) containing all its ingredients is heated to 80 ° C. in a water bath. A is emulsified in B with rotor-stator type stirring (apparatus of the Moritz company). Phase C is incorporated and allowed to return to room temperature with moderate stirring. The triethanolamine is introduced so as to adjust the pH to the desired value at the end of manufacture.

Claims (32)

  1. A cosmetic and / or dermatological aqueous composition comprising in a cosmetically acceptable support at least one UV radiation filtering system, characterized in that it contains: (a) at least one insoluble UV filter, and (b) at least one C-glycoside derivative.   2. A cosmetic and / or dermatological anhydrous composition comprising in a cosmetically acceptable support at least one UV radiation filtering system, characterized in that it contains: (a) at least one insoluble UV filter, and (b) at least one C-glycoside derivative.   3. Composition according to claim 1 or 2, wherein the insoluble UV filter (s) are selected from organic insoluble filters, inorganic insoluble filters and mixtures thereof.   4. Composition according to any one of Claims 1 to 3, in which the insoluble organic UV screening agent (s) is (are) chosen from those of the oxalanilide, triazine, benzotriazole, vinyl amide, cinnamide, benzazole or benzofuran type, Arylvinylidene ketone, acrylonitrile amide, acrylonitrile sulfonamide, acrylonitrile carbamate or phenylene-bis-benzoxazinone.   5. Composition according to any one of claims 1 to 3, wherein the one or more insoluble UV filter (s) organic (s) are selected from the polyvalent metal salts of sulfonated or carboxylated organic filters. 25   The composition of claim 5, wherein the at least one organic insoluble UV filter (s) is selected from polyvalent metal salts of sulfonated benzylidenecamphor derivatives; polyvalent metal salts of sulfonated benzimidazole derivatives and polyvalent metal salts of cinnamic acid derivatives.   7. Composition according to claim 4, wherein the organic insoluble UV filter (s) is (are) chosen from triazine or benzotriazole type UV filters.   The composition of claim 7, wherein the at least one organic UV-insoluble filter (s) is selected from 2,4,6-tris (biphenyl-4-yl-1,3,5-dichloroacetic acid). triazine) and 2,4,6-tris (terphenyl) -1,3,5-triazine. 2903008 62   9. Composition according to Claim 7, in which the organic insoluble UV filter (s) is (are) chosen from methylene-bis (hydroxyphenylbenzotriazole) derivatives having the following structure: ## STR5 ## in which R 8 and R 9 , identical or different, each represent a C 1 -C 18 alkyl radical which may be substituted with one or more radicals chosen from C 1 -C 4 alkyl, C 5 -C 12 cycloalkyl or aryl.   The composition of claim 9 wherein the organic insoluble UV filter is 2,2'-methylene-bis- [6- (2H-benzotriazol-2-yl) -4- (1,1,3,3- Tetramethylbutyl) phenol].   11. Composition according to any one of claims 1 to 10, wherein the one or more insoluble UV filter (s) organic (s) are in the form of particles of average size ranging from 10 nm to 5 m.   The composition of claim 11, wherein the average size ranges from 10 nm to 2 m, and in particular from 20 nm to 1.5 m, and more particularly from 30 nm to 1.0 m.   13. Composition according to any one of claims 1 to 12, wherein the one or more insoluble organic UV filter (s) are capable of being obtained by a method of grinding an insoluble organic UV filter. in the form of coarse particles in the presence of a surfactant or an amphiphilic copolymer comprising at least one hydrophilic block and at least one hydrophobic block.   The composition of claim 13, wherein the surfactant is selected from alkylpolyglucosides having the structure C 1, H 2n + (C 6 H 100 O) xH wherein n is an integer of 8 to 16 and x is the average degree of polymerization of unit (C6H1005) and varies from 1.4 to 1.6.   15. The composition of claim 14, wherein the surfactant is used at a concentration of from 1 to 50% by weight and more preferably from 5 to 40% by weight relative to the weight of organic insoluble filter. 2903008 63   16. Composition according to any one of claims 1 to 3, wherein the mineral insoluble or insoluble filters are selected from coated metal or not including titanium dioxide, oxides of iron, zinc, zirconium or cerium.   17. The composition of claim 16, wherein the inorganic insoluble filter (s) is in the form of titanium oxide-based pigments, coated or uncoated.   18. The composition of claim 17, wherein the titanium oxide is in rutile, anatase or amorphous form.   19. A composition according to any one of claims 16 to 18, wherein the UV insoluble mineral filter (s) have an average particle size greater than 5 nm and less than 100 nm, of preferably greater than 10 nm and less than 50 nm.   20. Composition according to any one of claims 1 to 19, wherein the insoluble UV filter (s) are present at a content expressed as active ingredient of between 0.1 and 35% by weight, and preferably between 0.5 and 25% by weight, relative to the total weight of the composition.   21. The composition as claimed in any one of the preceding claims, in which the C-glycoside derivative has the following general formula (I): ## STR2 ## in which: R represents: a linear alkyl radical; C1 to C20 saturated, in particular C1 to C10, unsaturated C2 to C20, in particular C2 to C10, or a branched or cyclic alkyl radical, saturated or unsaturated, C3 to C20, in particular C3 to C10; a linear hydrofluoro- or perfluoroalkyl radical, linear saturated C1 to C20, in particular C1 to C10, or unsaturated C2 to C20, in particular C2 to C10, or branched or cyclic, saturated or unsaturated, C3 to C20 especially C3 to Clo; the hydrocarbon chain constituting said radicals may, if necessary, be interrupted by 1, 2, 3 or more heteroatoms chosen from: - an oxygen, a sulfur, a nitrogen, and a silicon, and possibly being substituted by at least one radical chosen from: - OR4, - SR4, - -NR4R5, -COOR4, -CONHR4, --CN, a halogen atom, - a C1 to C6 hydrofluoro- or perfluoroalkyl radical, and / or a C3-C8 cycloalkyl radical, with R4 and R5 being independently of one another a hydrogen atom, or an alkyl, perfluoroalkyl or linear hydrofluoroalkyl radical, saturated with C 1 to C 30, in particular in C 1 to C 12, or unsaturated C 2 to C 30, especially C 2 to C 8, or branched or cyclic, saturated or unsaturated, C 3 to C 30, in particular C 3 to Cu; or a C 6 to C 10 aryl radical; X represents a radical chosen from the groups: OCN R 2 R, with R 1, R 2 and R 3 representing, independently of one another, a hydrogen atom, or a radical R with R as defined above, and R '1 representing a hydrogen atom, a group OH or a radical R as defined above, RI may also denote a C6 to C10 aryl radical, S represents a monosaccharide or a polysaccharide comprising up to 20 sugar units, in particular up to 6 sugar units, in pyranose and / or furanose and L and / or D series form, said mono- or polysaccharide being substitutable with a hydroxyl group which is necessarily free, and optionally one or more optionally protected amine function (s), and the S-CH2-X bond represents a C-anomeric bond, which may be a or 13, As well as their cosmetically acceptable salts, their solvates such as hydrates and their isomers.   22. Composition according to the preceding claim, wherein S represents a monosaccharide selected from D-glucose, D-xylose, L-fucose, D-galactose, D-maltose and especially D-xylose.   23. Composition according to the preceding claim, wherein X represents a group selected from CO-, -CH (OH) -, -CH (NH2) -, and preferably a group ùCH (OH) -.   24. Composition according to the preceding claim, in which R denotes a C1-C4 linear radical, especially C1-C3, optionally substituted with OH, -COOH or -COOR "2, R" 2 being a saturated C1-C4 alkyl radical. , especially ethyl.   25. A composition according to any one of the preceding claims, wherein the C-glycoside derivative is selected from: C- (3-D-xylopyranoside-n-propan-2-one, CaD-xylopyranoside-n-propane -2-one, C- (3-D-xylopyranoside-2-hydroxy-propane, CaD-xylopyranoside-2-hydroxy-propane, 1- (C- (3-D-fucopyranoside) -propane-2- one, 1- (CaD-fucopyranoside) -propan-2-one, 1- (C- (3-L-fucopyranoside) -propan-2-one, 1- (CaL-fucopyranoside) -propane -2-one, 1- (C- (3-D-fucopyranoside) -2-hydroxy-propane, 1- (CaD-fucopyranoside) -2-hydroxypropane, 1- (C-) L-fucopyranoside) -2-hydroxypropane, 1- (CaL-fucopyranoside) -2-hydroxypropane, 1- (C- (3-D-glucopyranosyl) -2-hydroxylpropane, (1- (C-β-D-galactopyranosyl) -2-hydroxylpropane, 1- (CaD-galactopyranosyl) -2-hydroxylpropane C- (3-D-fucofuranosyl) -propan-2-one, 1- (CaD-fucofuranosyl) -propan-2-one 1- (C- (3-L-fucofuranosyl) -pro pane-2-one, 1- (CaL-fucofuranosyl) -propan-2-one, C- (3-D-maltopyranoside-n-propan-2-one, - CaD-maltopyranoside-n-propane-2 -one C- (3-D-maltopyranoside-2-hydroxy-propane, - CaD-maltopyranoside-2-hydroxy-propane, their isomers and mixtures thereof.   26. Composition according to any one of the preceding claims, in which the C-glycoside derivative is chosen from C-β-D-xylopyranoside-2-hydroxypropane and CaD-xylopyranoside-2-hydroxypropane, and is more particularly the CPD-xylopyranoside-2-hydroxypropane. 20   27. Composition according to any one of the preceding claims, in which the C-glycoside derivative is present in a content ranging from about 0.0001% to about 25% by weight of active material relative to the total weight of the composition, and in particular from about 0.001% to about 10% by weight of active material, and more preferably from about 0.05% to about 5% by weight of active material based on the total weight of the composition.   28. Composition according to any one of the preceding claims, characterized in that it constitutes a skin care product, a skin makeup product, a sunscreen product or a daily photoprotection product or a product. cleaning the skin. 30   29. Composition according to the preceding claim, characterized in that it constitutes a sunscreen product or a daily photoprotection product. 5 10 2903008 67.   30. Process for the cosmetic treatment of a keratinous material, characterized in that a cosmetic composition according to any one of the preceding claims is applied to the keratinous material.   31. A cosmetic and / or dermatological assembly comprising: (i) a container defining at least one compartment, said container being closed by a closure member; and (ii) a composition according to any one of claims 1 to 29 and disposed within said compartment.   32. Use of at least one C-glycoside derivative for the preparation of a cosmetic and / or dermatological composition comprising, in a cosmetically acceptable support, at least one insoluble UV filter, intended to reduce bleaching and / or to improve the spreading and touch after application.